<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Fibrin glue instillation under skin flaps to prevent seroma‐related morbidity following breast and axillary surgery - Sajid, MS - 2013 | Cochrane Library</title> <meta content="Fibrin glue instillation under skin flaps to prevent seroma‐related morbidity following breast and axillary surgery - Sajid, MS - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009557.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Fibrin glue instillation under skin flaps to prevent seroma‐related morbidity following breast and axillary surgery - Sajid, MS - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009557.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009557.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Fibrin glue instillation under skin flaps to prevent seroma‐related morbidity following breast and axillary surgery" name="citation_title"/> <meta content="Muhammad S Sajid" name="citation_author"/> <meta content="Worthing Hospital, Western Sussex Hospitals NHS Trust" name="citation_author_institution"/> <meta content="Surgeon1wrh@hotmail.com" name="citation_author_email"/> <meta content="Kristian H Hutson" name="citation_author"/> <meta content="Worthing Hospital" name="citation_author_institution"/> <meta content="I. Fabio F Rapisarda" name="citation_author"/> <meta content="Worthing Hospital" name="citation_author_institution"/> <meta content="Riccardo Bonomi" name="citation_author"/> <meta content="Worthing Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD009557.pub2" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/05/31" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009557.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009557.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009557.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Axilla; Breast Neoplasms [*surgery]; Fibrin Tissue Adhesive [*administration &amp; dosage]; Hemostatics [*administration &amp; dosage]; Lymph Node Excision [*adverse effects]; Postoperative Complications [*prevention &amp; control]; Randomized Controlled Trials as Topic; Seroma [*prevention &amp; control]; *Surgical Flaps; Treatment Failure" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009557.pub2&amp;doi=10.1002/14651858.CD009557.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="EBp84H4P";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009557\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009557\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009557\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009557\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANT","fa","fr","ms"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009557.pub2",title:"Fibrin glue instillation under skin flaps to prevent seroma\\u2010related morbidity following breast and axillary surgery",firstPublishedDate:"May 31, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Breast Cancer Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=EBp84H4P&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009557.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009557.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009557.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009557.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009557.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009557.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009557.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009557.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009557.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009557.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1357 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009557.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/full#CD009557-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/full#CD009557-sec-0084"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/full#CD009557-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/full#CD009557-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/full#CD009557-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/full#CD009557-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/full#CD009557-sec-0042"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/full#CD009557-sec-0078"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/appendices#CD009557-sec-0089"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/table_n/CD009557StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/table_n/CD009557StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Fibrin glue instillation under skin flaps to prevent seroma‐related morbidity following breast and axillary surgery </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/information#CD009557-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Muhammad S Sajid</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/information#CD009557-cr-0005">Kristian H Hutson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/information#CD009557-cr-0006">I. Fabio F Rapisarda</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009557.pub2/information#CD009557-cr-0007">Riccardo Bonomi</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/information/en#CD009557-sec-0100">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 31 May 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009557.pub2">https://doi.org/10.1002/14651858.CD009557.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009557-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009557-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009557-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009557-abs-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009557-abs-0006">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009557-abs-0001" lang="en"> <section id="CD009557-sec-0001"> <h3 class="title" id="CD009557-sec-0001">Background</h3> <p>Fibrin glue (FG) combines fibrinogen and thrombin, under the presence of factor XIII and calcium chloride, and produces a 'fibrin clot' as would occur through the natural clotting cascade. FG is thought to close over any small vessels including lymphatics that are too small for conventional surgical closure, thereby reducing seroma formation, seroma incidence and related comorbidities. </p> </section> <section id="CD009557-sec-0002"> <h3 class="title" id="CD009557-sec-0002">Objectives</h3> <p>To assess the evidence on the effectiveness of FG in people undergoing breast and axillary surgery and to establish whether FG is an efficient modality to prevent postoperative seroma and seroma‐related outcomes. </p> </section> <section id="CD009557-sec-0003"> <h3 class="title" id="CD009557-sec-0003">Search methods</h3> <p>We searched the Cochrane Breast Cancer Group's (CBCG) Specialised Register (9 December 2011), the Cochrane Central Register of Controlled Trials (CENTRAL, Issue 1 2012), MEDLINE (9 December 2011), EMBASE (9 December 2011), LILACS (22 October 2012), SCI‐E (22 October 2012), the World Health Organization's International Clinical Trial Registry (9 December 2011) and ClinicalTrials.gov (22 October 2012). </p> </section> <section id="CD009557-sec-0004"> <h3 class="title" id="CD009557-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) comparing the effectiveness of FG in terms of reducing the postoperative seroma incidence and related comorbidities in people undergoing breast and axillary surgery. </p> </section> <section id="CD009557-sec-0005"> <h3 class="title" id="CD009557-sec-0005">Data collection and analysis</h3> <p>At least two review authors independently scrutinised search results, selected eligible studies and extracted the data. The pooled analysis of the extracted data was achieved by the statistical analysis on Review Manager software. The quality of studies was assessed using The Cochrane Collaboration's 'Risk of bias' tool. </p> </section> <section id="CD009557-sec-0006"> <h3 class="title" id="CD009557-sec-0006">Main results</h3> <p>The search of four standard electronic databases yielded 119 potentially relevant studies but only 18 RCTs involving 1252 people were found suitable for statistical analysis. There was significant heterogeneity among trials and the majority of trials were of poor quality. The use of FG under skin flaps following breast and axillary surgery failed to reduce the incidence of postoperative seroma (risk ratio (RR) 1.02; 95% Confidence Interval (CI) 0.90 to 1.16, P value = 0.73), mean volume of seroma (standardised mean difference (SMD) ‐0.25; 95% CI ‐0.92 to 0.42, P value = 0.46), wound infection (RR 1.05; 95% CI 0.63 to 1.77, P value = 0.84), postoperative complications (RR 1.13; 95% CI 0.63 to 2.04, P value = 0.68) and length of hospital stay (SMD ‐0.2; 95% CI ‐0.78 to 0.39, P value = 0.51). FG reduced the total volume of drained seroma (SMD ‐0.75, 95% CI ‐1.24 to ‐0.26, P value = 0.003) and duration of persistent seromas requiring frequent aspirations (SMD ‐0.59; CI 95% ‐0.95 to ‐0.23, P value = 0.001). </p> </section> <section id="CD009557-sec-0007"> <h3 class="title" id="CD009557-sec-0007">Authors' conclusions</h3> <p>FG did not influence the incidence of postoperative seroma, the mean volume of seroma, wound infections, complications and the length of hospital stays in people undergoing breast cancer surgery. Due to significant methodological and clinical diversity among the included studies this conclusion may be considered weak and biased. Therefore, a major multicentre and high‐quality RCT is required to validate these findings. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009557-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009557-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009557-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009557-abs-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009557-abs-0007">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD009557-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD009557-abs-0003">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009557-abs-0002" lang="en"> <h3>Fibrin glue instillation under skin flaps to prevent seroma‐related morbidity following breast and axillary surgery </h3> <p>A higher incidence of postoperative seroma (fluid collection under skin) in people undergoing breast and axillary (under‐arm) surgery for breast cancer is responsible for longer hospital stays, frequent repeat aspiration procedures, increased cost of breast disease, delays in the provision of adjunctive treatments and consequently potentially reduced overall all‐cause survival. Fibrin glue (FG) instillation under skin flaps after surgery produces a 'fibrin clot', sealing leaky lymph vessels, which leads to reduced seroma formation and related comorbidities. </p> <p>We systematically analysed the published trials comparing the usefulness of FG as a small‐vessel sealing agent. Eighteen randomised controlled trials on 1252 people were retrieved following bibliographic searches on standard medical databases. There were significant clinical and methodological differences among the included trials. The use of FG following breast and axillary surgery did not reduce the incidence of postoperative seroma, mean volume of seroma, wound infections, postoperative complications and the length of hospital stays. FG reduced the total volume of drained seroma and the duration of persistent seroma requiring frequent aspirations. </p> <p>This review showed no overall benefit of using FG. Although this conclusion is based on the combined analysis of 18 trials, the majority of these were of poor quality due to flaws in trial methods. Therefore, this conclusion should be taken cautiously and a major, multicentre, high‐quality randomised controlled trial on people undergoing breast and axillary surgery for breast cancer is required to corroborate this conclusion. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009557-sec-0084" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009557-sec-0084"></div> <h3 class="title" id="CD009557-sec-0085">Implications for practice</h3> <section id="CD009557-sec-0085"> <p>At present, there is no high‐quality evidence available to suggest that FG is either effective or ineffective in reducing the incidence of postoperative seroma and related morbidities in people undergoing breast and axillary surgery for breast cancer. There is significant clinical and methodological diversity among the published RCTs investigating the role of FG and with variable outcomes and conclusions. Despite having several limitations in this review, we still believe that the meta‐analysis presented in this review provides the current, best available evidence in making the clinical decision about the role of FG in breast and axillary surgery. </p> </section> <h3 class="title" id="CD009557-sec-0086">Implications for research</h3> <section id="CD009557-sec-0086"> <p>The conclusion of this review opens the channels for further research on this very important area of breast and oncoplastic surgery. A major, multicentre, RCT of high quality is required in order to strengthen the current evidence. Trials on participants with various types of surgery such as simple mastectomy, MRM, breast‐conserving surgery, axillary dissection, axillary sampling and sentinel node biopsy should be conducted separately to find which group may benefit more from the application of FG. Studies on the use of FG in people undergoing simultaneous oncoplastic procedures should also be performed to define actual effectiveness. Trials should be conducted in such a manner that the effect of confounding and adjunctive procedures can be excluded. Methodologically sound and robust RCTs are needed in order to investigate the role of various commercial brands of FG. RCTs evaluating the economic impact of FG, long‐term effectiveness of FG and HRQoL should be conducted. When conducting and reporting RCTs, the investigators should follow the CONSORT statement for reporting controlled trials (<a href="./references#CD009557-bbs2-0034" title="MoherD , HopewellS , SchulzKF , MontoriV , GøtzschePC, DevereauPJ . CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ2010;23:240.">CONSORT 2010</a>) so that the RCTs can be precisely and accurately evaluated by readers and reviewers. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009557-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009557-sec-0008"></div> <div class="table" id="CD009557-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Fibrin glue instillation under skin flaps compared to no‐fibrin for breast and axillary surgery</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Fibrin glue instillation under skin flaps compared to no‐fibrin for breast and axillary surgery</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with breast and axillary surgery<br/><b>Settings:</b> <br/><b>Intervention:</b> fibrin glue instillation under skin flaps<br/><b>Comparison:</b> no‐fibrin </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No‐fibrin</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Fibrin glue instillation under skin flaps</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Incidence of</b> postoperative<b>seroma</b><br/>RR<br/>Follow‐up: 4‐16 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.02</b> <br/>(0.9 to 1.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1252<br/>(18 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>281 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>286 per 1000</b><br/>(253 to 326) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>229 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>234 per 1000</b><br/>(206 to 266) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean volume of seroma</b><br/>SMD<br/>Follow‐up: 4‐16 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean volume of seroma in the intervention groups was<br/><b>0.25 standard deviations lower</b><br/>(0.92 lower to 0.42 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>731<br/>(10 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.25 (‐0.92 to 0.42)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total volume of drained seroma</b><br/>SMD<br/>Follow‐up: 4‐16 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean total volume of drained seroma in the intervention groups was<br/><b>0.75 standard deviations lower</b><br/>(1.24 to 0.26 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>888<br/>(13 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.75 (‐1.24 to ‐0.26)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of days for persistent drainage</b><br/>SMD<br/>Follow‐up: 4‐16 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of days for persistent drainage in the intervention groups was<br/><b>0.59 standard deviations lower</b><br/>(0.95 to 0.23 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>861<br/>(13 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.59 (‐0.95 to ‐0.23)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Surgical site infection</b><br/>RR<br/>Follow‐up: 4‐16 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.05</b> <br/>(0.63 to 1.77) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1009<br/>(13 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>48 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 1000</b><br/>(30 to 85) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 1000</b><br/>(16 to 44) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Postoperative<b>complications</b><br/>RR<br/>Follow‐up: 4‐16 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.13</b> <br/>(0.63 to 2.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>981<br/>(11 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>39 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>44 per 1000</b><br/>(24 to 79) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>44 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 1000</b><br/>(28 to 90) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Length of hospital stay</b><br/>SMD<br/>Follow‐up: 4‐16 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay in the intervention groups was<br/><b>0.2 standard deviations lower</b><br/>(0.78 lower to 0.39 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>364<br/>(6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.2 (‐0.78 to 0.39)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>SMD:</b> standardised mean difference. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> There was inadequate randomisation technique and absence of power calculations, blinding and intention‐to‐treat analysis. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009557-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009557-sec-0009"></div> <section id="CD009557-sec-0010"> <h3 class="title" id="CD009557-sec-0010">Description of the condition</h3> <p>Breast cancer remains the second most common cancer in women with a reported mortality reaching 460,000 deaths worldwide in 2008 (<a href="./references#CD009557-bbs2-0089" title="Cancer facts sheet No. 297. World Health Organization. New York, USA: WHO, 2011. www.who.int/mediacentre/factsheets/fs297/en/ [Accessed on 04.07.2011].">WHO 2011</a>). Surgical resection of the breast cancer is the only mode of curative intervention. Surgical management consists primarily of tumour resection and is frequently associated with either axillary sentinel node biopsy or axillary sampling, or axillary dissection/clearance. The extent of surgical resection is determined by tumour type, size and stage and can involve a modified radical mastectomy (MRM) or more limited breast‐conserving operations such as lumpectomy, wide local excision and quadrantectomy (<a href="./references#CD009557-bbs2-0039" title="deLorenziF . Oncoplastic surgery: the evolution of breast cancer treatment. The Breast Journal2010;16 Suppl 1:S20-1.">de Lorenzi 2010</a>; <a href="./references#CD009557-bbs2-0041" title="DenewerA , FaroukO , MostafaW , ElshamyK . Social support and hope among Egyptian women with breast cancer after mastectomy. Breast cancer: basic and clinical research (Auckland)2011;5:93-103.">Denewer 2011</a>; <a href="./references#CD009557-bbs2-0060" title="KrekelNM , ZonderhuisBM , SchreursHW , CardozoAM , RijnaH , van derVeenH , et al. Ultrasound-guided breast-sparing surgery to improve cosmetic outcomes and quality of life. A prospective multicentre randomised controlled clinical trial comparing ultrasound-guided surgery to traditional palpation-guided surgery (COBALT trial). BMC Surgery2011;11:8.">Krekel 2011</a>; <a href="./references#CD009557-bbs2-0063" title="LoukasM , TubbsRS , MirzayanN , ShirakM , SteinbergA , ShojaMM . The history of mastectomy. The American Surgeon2011;77:566-71.">Loukas 2011</a>; <a href="./references#CD009557-bbs2-0077" title="SakorafasGH , SafioleasM . Breast cancer surgery: an historical narrative. Part III. From the sunset of the 19th to the dawn of the 21st century. European Journal of Cancer Care (England)2010;19:145-66.">Sakorafas 2010</a>). </p> <p>Seroma formation is the most common postoperative complication following breast cancer surgery (<a href="./references#CD009557-bbs2-0023" title="BoostromSY , ThrockmortonAD , BougheyJC , HolifieldAC , ZakariaS , HoskinTL , et al. Incidence of clinically significant seroma after breast and axillary surgery. Journal of the American College of Surgeons2009;208:148-50.">Boostorm 2009</a>; <a href="./references#CD009557-bbs2-0046" title="FerreiraBP , PimentelMD , SantosLC , di FloraW , GobbiH . Morbidity after sentinel node biopsy and axillary dissection in breast cancer. Revista da Associação Médica Brasileira2008;54:517-21.">Ferreira 2008</a>; <a href="./references#CD009557-bbs2-0049" title="GongY , XuJ , ShaoJ , ChengH , WuX , ZhaoD , et al. Prevention of seroma formation after mastectomy and axillary dissection by lymph vessel ligation and dead space closure: a randomized trial. American Journal of Surgery2010;200:352-6.">Gong 2010</a>; <a href="./references#CD009557-bbs2-0062" title="KuroiK , ShimozumaK , TaguchiT , ImaiH , YamashiroH , OhsumiS , et al. Pathophysiology of seroma in breast cancer. Breast Cancer2005;12:288-93.">Kuroi 2005</a>; <a href="./references#CD009557-bbs2-0079" title="SaratzisA , SoumianS , WillettsR , RastallS , StonelakePS . Use of multiple drains after mastectomy is associated with more patient discomfort and longer postoperative stay. Clinical Breast Cancer2009;9:243-6.">Saratzis 2009</a>). Although rarely serious, seroma formation can predispose to surgical site infection; skin flap dehiscence or necrosis, or both; a requirement for continued aspirations; extended recovery time; delayed start of neoadjuvant chemotherapy or radiotherapy influencing disease‐free survival; and an overall longer hospital stay (<a href="./references#CD009557-bbs2-0025" title="BraithwaiteD , SatarianoWA , SternfeldB , HiattRA , GanzPA , KerlikowskeK , et al. Long-term prognostic role of functional limitations among women with breast cancer. Journal of the National Cancer Institute2010;102:1468-77.">Braithwaite 2010</a>; <a href="./references#CD009557-bbs2-0054" title="HoeferRA , DuboisJJ , OstrowLB , SilverLF . Wound complications following modified radical mastectomy: an analysis of perioperative factors. The Journal of the American Osteopathic Association1990;90:47-53.">Hoefer 1990</a>; <a href="./references#CD009557-bbs2-0067" title="SandersRP , GoodmanNC , Amiss LR Jr, PierceRA , MooreMM , MarxG , et al. Effect of fibrinogen and thrombin concentrations on mastectomy seroma prevention. The Journal of Surgical Research1996;61:65-70.">Moore 1996</a>; <a href="./references#CD009557-bbs2-0070" title="PinnaròP , RamboneR , GiordanoC , GiannarelliD , StrigariL , ArcangeliG . Long-term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34:238-44.">Pinnaro 2011</a>; <a href="./references#CD009557-bbs2-0091" title="WoodworthPA , McboyleMF , HelmerSD , BeamerRL . Seroma formation after breast cancer surgery: incidence and predicting factors. The American Surgeon2000;66:444-50.">Woodworth 2000</a>). </p> <p>The reported incidence of postoperative wound seroma following breast and axillary surgery ranges from 10% to 85% within the medical literature (<a href="./references#CD009557-bbs2-0062" title="KuroiK , ShimozumaK , TaguchiT , ImaiH , YamashiroH , OhsumiS , et al. Pathophysiology of seroma in breast cancer. Breast Cancer2005;12:288-93.">Kuroi 2005</a>). Two fundamental issues partly underlie why such a large range of seroma incidence was reported in the medical literature. First, there is a lack of consensus on the definition of a seroma; the majority of articles describe a seroma as a palpable fluid collection under the wound; however, some studies have stipulated that a seroma is present only when multiple aspirations are required (<a href="./references#CD009557-bbs2-0028" title="Burak WE Jr, GoodmanPS , YoungDC , FarrarWB . Seroma formation following axillary dissection for breast cancer: risk factors and lack of influence of bovine thrombin. Journal of Surgical Oncology1997;64:27-31.">Burak 1997</a>), or an aspirate over a specific volume is recorded, or both (<a href="./references#CD009557-bbs2-0061" title="KumarS , LalB , MisraMC . Post-mastectomy seroma: a new look into the aetiology of an old problem. Journal of the Royal College of Surgeons of Edinburgh1995;40:292-4.">Kumar 1995</a>; <a href="./references#CD009557-bbs2-0080" title="SchultzI , BarholmM , GröndalS . Delayed shoulder exercises in reducing seroma frequency after modified radical mastectomy: a prospective randomized study. Annals of Surgical Oncology1997;4:293-7.">Schultz 1997</a>). Second, where some authors detect seromas on clinical grounds of a palpable fluid collection, other authors utilise ultrasound to quantify the presence of seroma at the wound site accurately, resulting in the detection of subclinical fluid collections. The reported seroma incidence is therefore dictated by both author definition and the detection method used. The exact cellular composition of a seroma is also in contention. Some studies postulate an excess of lymph (<a href="./references#CD009557-bbs2-0083" title="TadychK , DoneganWL . Postmastectomy seromas and wound drainage. Surgery, Gynecology and Obstetrics1987;165:483-7.">Tadych 1987</a>), while others have suggested that the fluid production results from an acute inflammatory process and, as such, is an exudate in nature (<a href="./references#CD009557-bbs2-0064" title="McCaulJA , AslaamA , SpoonerRJ , LoudenI , CavanaghT , PurushothamAD . Aetiology of seroma formation in patients undergoing surgery for breast cancer. Breast2000;9:144-8.">McCaul 2000</a>; <a href="./references#CD009557-bbs2-0088" title="Watt-BoolsenS , NielsenVB , JensenJ , BakS . Post mastectomy seroma. A study of the nature and origin of seroma after mastectomy. Danish Medical Bulletin1989;36:487-9.">Watt‐Boolsen 1989</a>). Understanding the pathophysiology of seroma development has major implications on the therapeutic targets and likely confounding factors. Factors thought to affect seroma development include the person's age, body mass index (BMI), tumour size, use of neoadjuvant chemotherapy (<a href="./references#CD009557-bbs2-0091" title="WoodworthPA , McboyleMF , HelmerSD , BeamerRL . Seroma formation after breast cancer surgery: incidence and predicting factors. The American Surgeon2000;66:444-50.">Woodworth 2000</a>), type of surgery (MRM versus breast‐conserving surgery), axillary lymph node status, axillary lymph nodes sampled or removed, and subsequently the extent of surgical dead space produced. </p> </section> <section id="CD009557-sec-0011"> <h3 class="title" id="CD009557-sec-0011">Description of the intervention</h3> <p>A lack of thorough understanding of seroma composition, formation and resolution is still posing a significant challenge to breast surgeons. A number of technical procedures or adjunct therapies, or both, have been tried to counteract the proposed aetiological factors involved in seroma development in an attempt to reduce wound site drainage postoperatively and subsequently seroma formation. The most commonly tested strategy to reduce the incidence of seroma following breast or axillary surgery comprises drainage at the wound site (<a href="./references#CD009557-bbs2-0036" title="CorionLU , SmeuldersMJ , vanZuijlenPP , van derHorstCM . Draining after breast reduction: a randomised controlled inter-patient study. Journal of Plastic, Reconstructive and Aesthetic Surgery2009;62:865-8.">Corion 2009</a>). Drainage of the dead space after mastectomy or axillary dissection has been reported with the use of half versus full suction drains (<a href="./references#CD009557-bbs2-0033" title="Chintamani, SinghalV , SinghJ , BansalA , SaxenaS . Half versus full vacuum suction drainage after modified radical mastectomy for breast cancer - a prospective randomized clinical trial. BMC Cancer2005;5:11.">Chintamani 2005</a>), non‐suction drains (<a href="./references#CD009557-bbs2-0043" title="DivinoCM , KuererHM , TartterPI . Drains prevent seromas following lumpectomy with axillary dissection. The Breast Journal2000;6:31-3.">Divino 2000</a>), no drains (<a href="./references#CD009557-bbs2-0072" title="PuttawibulP , SangthongB , MaipangT , SampaoS , UttamakulP , ApakupakulN . Mastectomy without drain at pectoral area: a randomized controlled trial. Journal of the Medical Association of Thailand2003;86:325-31.">Puttawibul 2003</a>), drains for five days versus eight days (<a href="./references#CD009557-bbs2-0050" title="GuptaR , PateK , VarshneyS , GoddardJ , RoyleGT . A comparison of 5-day and 8-day drainage following mastectomy and axillary. European Journal of Surgical Oncology2001;27:26-30.">Gupta 2001</a>), single versus multiple drains (<a href="./references#CD009557-bbs2-0069" title="PetrekJA , PetersMM , CirrincioneC , ThalerHT . A prospective randomized trial of single versus multiple drains in the axilla after lymphadenectomy. Surgery, Gynecology and Obstetrics1992;175:405-9.">Petrek 1992</a>), axillary versus axillary and pectoral drains (<a href="./references#CD009557-bbs2-0085" title="TerrellGS , SingerJA . Axillary versus combined axillary and pectoral drainage after modified radical mastectomy. Surgery, Gynecology and Obstetrics1992;175:437-40.">Terrell 1992</a>), and the use of suction versus corrugated drains (<a href="./references#CD009557-bbs2-0024" title="BourkeJB , BalfourTW , HardcastleJD , WilkinsJL . A comparison between suction and corrugated drainage after simple mastectomy: a report of a controlled trial. The British Journal of Surgery1976;63:67-9.">Bourke 1976</a>). A reduction in dead space by suture fixation (<a href="./references#CD009557-bbs2-0037" title="DanceyAL , CheemaM , ThomasSS . A prospective randomized trial of the efficacy of marginal quilting sutures and fibrin sealant in reducing the incidence of seromas in the extended latissimus dorsi donor site. Plastic and Reconstructive Surgery2010;125:1309-17.">Dancey 2010</a>), or external compression dressing, or both, is also reported (<a href="./references#CD009557-bbs2-0068" title="O'HeaBJ , HoMN , PetrekJA . External compression dressing versus standard dressing after axillary lymphadenectomy. American Journal of Surgery1999;177:450-3.">O'Hea 1999</a>), with a variable success rate. Use of mastectomy flap dissection tools, ultrasound scissors, electrocautery and scalpel dissection (<a href="./references#CD009557-bbs2-0048" title="GalatiusH , OkholmM , HoffmannJ . Mastectomy using ultrasonic dissection: effect on seroma formation. Breast2003;12:338-41.">Galatius 2003</a>; <a href="./references#CD009557-bbs2-0058" title="KozomaraD , GalićG , BrekaloZ , SutaloN , KvesićA , SoljićM . A randomised two-way comparison of mastectomy performed using harmonic scalpel or monopolar diathermy. Collegium Antropologicum2010;34 Suppl 1:105-12.">Kozomara 2010</a>; <a href="./references#CD009557-bbs2-0071" title="PorterKA , O'ConnorS , RimmE , LopezM . Electrocautery as a factor in seroma formation following mastectomy. American Journal of Surgery1998;176:8-11.">Porter 1998</a>) have been evaluated with equivocal results. Other seroma reduction interventions after mastectomy and axillary dissection include postoperative shoulder immobilisation to prevent shearing forces at the wound site (<a href="./references#CD009557-bbs2-0031" title="ChenSC , ChenMF . Timing of shoulder exercise after modified radical mastectomy: a prospective study. Changgeng Yi Xue Za Zhi1999;22:37-43.">Chen 1999</a>), use of tetracycline sclerotherapy (<a href="./references#CD009557-bbs2-0074" title="RiceDC , MorrisSM , SarrMG , FarnellMB , vanHeerdenJA , GrantCS , et al. Intraoperative topical tetracycline sclerotherapy following mastectomy: a prospective, randomized trial. Journal of Surgical Oncology2000;73:224-7.">Rice 2000</a>) or talc poudrage (<a href="./references#CD009557-bbs2-0035" title="CoonsMS , FolliguetTA , RodriguezC , WoloszynTT , TuchlerRE , MariniCP . Prevention of seroma formation after dissection of musculocutaneous flaps. The American Surgeon1993;59:215-8.">Coons 1993</a>) underneath skin flaps, various sealants (<a href="./references#CD009557-bbs2-0084" title="TaflampasP , SanidasE , ChristodoulakisM , AskoxylakisJ , MelissasJ , TsiftsisDD . Sealants after axillary lymph node dissection for breast cancer: good intentions but bad results. American Journal of Surgery2009;198:55-8.">Taflampas 2009</a>), ketoprofen therapy (<a href="./references#CD009557-bbs2-0051" title="HidarS , SoussiK , BibiM , KhairiH . Influence of ketoprofen on drainage volume after radical breast cancer surgery: a prospective randomized clinical trial. Turkish-German Gynecological Association2007;8:71-5.">Hidar 2007</a>), coated collagen patches (<a href="./references#CD009557-bbs2-0019" title="BergerA , TempferC , HartmannB , KornpratP , RossmannA , NeuwirthG , et al. Sealing of postoperative axillary leakage after axillary lymphadenectomy using a fibrin glue coated collagen patch: a prospective randomised study. Breast Cancer Research and Treatment2001;67(1):9-14. ">Berger 2001</a>), bovine thrombin instillation (<a href="./references#CD009557-bbs2-0028" title="Burak WE Jr, GoodmanPS , YoungDC , FarrarWB . Seroma formation following axillary dissection for breast cancer: risk factors and lack of influence of bovine thrombin. Journal of Surgical Oncology1997;64:27-31.">Burak 1997</a>), and fibrin glue (FG) or spray (<a href="./references#CD009557-bbs2-0029" title="CarlessPA , HenryDA . Systematic review and meta-analysis of the use of fibrin sealant to prevent seroma formation after breast cancer surgery. The British Journal of Surgery2006;93:810-9.">Carless 2006</a>; <a href="./references#CD009557-bbs2-0076" title="RuggieroR , ProcacciniE , PiazzaP , DocimoG , IovinoF , AntoniolG , et al. Effectiveness of fibrin glue in conjunction with collagen patches to reduce seroma formation after axillary lymphadenectomy for breast cancer. American Journal of Surgery2008;196:170-4.">Ruggiero 2008</a>; <a href="./references#CD009557-bbs2-0013" title="RuggieroR , ProcacciniE , GiliS , CremoneC , ParmeggianiD , ConzoG , et al. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. Il Giornale di Chirurgia2009;30:306-10. ">Ruggiero 2009</a>). </p> <p>Fibrin sealants have been used in surgery since the early 1980s. Their potential role as a haemostatic and sealing agent has expanded across a wide range of surgical disciplines, such as cardiac surgery, vascular surgery, hepatobiliary surgery, partial splenectomy, cosmetic surgery, orthopaedic surgery and gynaecological surgery (<a href="./references#CD009557-bbs2-0026" title="BriceñoJ , NaranjoA , CiriaR , Díaz-NietoR , Sánchez-HidalgoJM , LuqueA , et al. A prospective study of the efficacy of clinical application of a new carrier-bound fibrin sealant after liver resection. Archives of Surgery2010;145:482-8.">Briceno 2010</a>; <a href="./references#CD009557-bbs2-0027" title="BrielerHS , BirkerT , ElfeldH , SeifertJ . Effectiveness of various methods of stopping hemorrhage in spleen and liver injuries - results of an animal experiment study. Zeitschrift für experimentelle Chirurgie, Transplantation, und künstliche Organe1986;19:94-9.">Brieler 1986</a>; <a href="./references#CD009557-bbs2-0047" title="FranceschiD , MadsenT , WeatherfordC , ChapmanJR . A multicenter randomized clinical trial using fibrin sealant, produced by the Cryoseal® FS system in patients undergoing liver resection. Transfusion Alternatives in Transfusion Medicine2006;8 Suppl 1:92.">Franceschi 2006</a>; <a href="./references#CD009557-bbs2-0059" title="KramHB , NathanRC , StaffordFJ , FlemingAW , ShoemakerWC . Fibrin glue achieves haemostasis in patients with coagulation disorders. Archives of Surgery1989;124:385-7.">Kram 1989</a>; <a href="./references#CD009557-bbs2-0065" title="ModiP , RahamimJ . Fibrin sealant treatment of splenic injuries during oesophagectomy. European Journal of Cardiothoracic Surgery2005;28:167-8.">Modi 2005</a>; <a href="./references#CD009557-bbs2-0082" title="SierraDH . Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications. Journals of Biomaterials Applications1993;7:309-52.">Sierra 1993</a>). Following completion of axillary and breast surgery, FG is sprayed over raw wound areas underneath the skin flaps and an adjunctive pressure dressing is applied. Suction drains, non‐suction drains and upper‐limb physiotherapy may also be applied depending upon the surgeon's choice. FG seals leaking lymph and other vessels and subsequently reduces the seroma formation. </p> </section> <section id="CD009557-sec-0012"> <h3 class="title" id="CD009557-sec-0012">How the intervention might work</h3> <p>Since the first reports of FG alleviating seroma production following mastectomy in animal models (<a href="./references#CD009557-bbs2-0045" title="EroğluE , OralS , UnalE , KalayciM , OksüzO , TilmazM . Reducing seroma formation with fibrin glue in an animal mastectomy model. European Journal of Surgical Oncology1996;22:137-9.">Eroglu 1996</a>; <a href="./references#CD009557-bbs2-0078" title="SandersRP , GoodmanNC , Amiss LR Jr, PierceRA , MooreMM , MarxG , et al. Effect of fibrinogen and thrombin concentrations on mastectomy seroma prevention. The Journal of Surgical Research1996;61:65-70.">Sanders 1996</a>; <a href="./references#CD009557-bbs2-0087" title="WangJY , GoodmanNC , Amiss LR Jr, NguyenDH , RodeheaverGT , MooreMM , et al. Seroma prevention in a rat mastectomy model: use of a light-activated fibrin sealant. Annals of Plastic Surgery1996;37:400-5.">Wang 1996</a>), it has been considered one of the most frequently scrutinised and reported modalities in humans after breast and axillary surgery. FG combines fibrinogen and thrombin and in the presence of factor XIII and calcium chloride produces a 'fibrin clot''', as would occur through the natural clotting cascade. FG is thought to act as both a haemostatic agent and as an adhesive, closing over any small vessels, including lymphatics, that are too small for conventional surgical closure (<a href="./references#CD009557-bbs2-0075" title="RousouJA , EnglemanRM , BreyerRH . Fibrin glue: an effective homeostatic agent for non-suturable intraoperative bleeding. Annals of Thoracic Surgery1984;38:409.">Rousou 1984</a>). </p> </section> <section id="CD009557-sec-0013"> <h3 class="title" id="CD009557-sec-0013">Why it is important to do this review</h3> <p>We aim to review the published literature to establish whether FG is an effective modality for seroma prevention following breast and axillary surgery. It is important to establish that routine use of FG under skins flaps can prevent the consequences of seroma and related morbidities. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009557-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009557-sec-0014"></div> <p> <ol id="CD009557-list-0001"> <li> <p>To determine whether the application of FG following breast cancer surgery reduces the incidence of seroma formation. </p> </li> <li> <p>To determine the effect of FG on the total drain volume, mean volume of seroma aspirate, frequency of wound infection or complications and the length of hospital stay. </p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009557-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009557-sec-0015"></div> <section id="CD009557-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009557-sec-0017"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) comparing the effectiveness of FG in terms of reducing the incidence of seroma and its related morbidity following breast and axillary surgery for breast cancer. We considered the inclusion of trials published in all languages regardless of the number of participants, their age and gender. We excluded trials recruiting people with redo surgery, trials evaluating outcomes other than our intended primary outcome, people with recurrent disease, people having chemotherapy or radiotherapy and people with a diagnosis of renal failure, heart failure or liver failure. </p> </section> <section id="CD009557-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included trials recruiting people with breast cancer undergoing simple mastectomy, MRM, breast‐conserving surgery, oncoplastic breast surgery, lumpectomy, quadrantectomy, axillary sentinel node biopsy, axillary sampling, axillary dissection of any level, and immediate partial or total breast reconstruction. </p> </section> <section id="CD009557-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We compared outcomes following the use of FG underneath skin flaps in people undergoing breast and axillary surgery. Seroma incidence and related morbidity were compared between groups of people receiving FG instillation under the skin flaps versus no use of FG. We also included trials in which other adjunctive therapies of seroma prevention were used, such as pressure dressing, single drain, multiple drains, suction drains and use of other adhesives or sealants. </p> </section> <section id="CD009557-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD009557-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD009557-list-0002"> <li> <p>Incidence of seroma, defined as the presence of fluid collection under the skin flap diagnosed by clinical and radiological assessment and requiring prolonged hospital stay, frequent clinic visits or aspiration(s), or a combination of these. </p> </li> <li> <p>Morbidity, including all adverse events such as wound infection, seroma, skin necrosis, shoulder stiffness, respiratory tract infection, urinary tract infection, deep vein thrombosis, pulmonary embolism, bleeding and haematoma. </p> </li> </ul> </p> </section> <section id="CD009557-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD009557-list-0003"> <li> <p>Long‐term morbidity up until five years after surgery.</p> </li> <li> <p>Long‐term mortality up until five years after surgery.</p> </li> <li> <p>Cost analysis using various health economic decision models (<a href="./references#CD009557-bbs2-0090" title="WilliamsC , BrunskillS , AltmanD , BriggsA , CampbellH , ClarkeM , et al. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy. Health Technology Assessment2006;10(34):iii-iv, ix-xi, 1-204.">William 2006</a>). </p> </li> <li> <p>Health‐related quality of life (HRQoL) using any measuring tool such as the European Organisation for Research and Treatment of Cancer (EORTC) breast cancer‐specific quality of life questionnaire (QLQ BR‐23), Functional Assessment of Cancer Therapy (FACT‐B), Hopwood Body Image Scale (HBIS), Body Image After Breast Cancer Questionnaire (BIBCQ) and BREAST‐Q (<a href="./references#CD009557-bbs2-0032" title="ChenCM , CanoSJ , KlassenAF , KingT , McCarthyC , CordeiroPG , et al. Measuring quality of life in oncologic breast surgery: a systematic review of patient-reported outcome measures. The Breast Journal2010;16(6):587-97.">Chen 2010</a>). </p> </li> <li> <p>Seroma volume (measured radiologically as well on aspiration, if required).</p> </li> <li> <p>Re‐intervention rate.</p> </li> <li> <p>Length of hospital stay, in days.</p> </li> <li> <p>Any other variable that was evaluated in the RCT that authors consider to be an important outcome. </p> </li> </ul> </p> </section> </section> </section> <section id="CD009557-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <p><a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/BREASTCA/frame.html" target="_blank">See: Breast Cancer Group methods used in reviews.</a> </p> <section id="CD009557-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We searched the following electronic databases.</p> <p> <ul id="CD009557-list-0004"> <li> <p>The Cochrane Breast Cancer Group (CBCG) Specialised Register. Details of the search strategies used by the CBCG for the identification of studies and the procedure used to code references are outlined in the Group's module (<a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/BREASTCA/frame.html" target="_blank">www.mrw.interscience.wiley.com/cochrane/clabout/articles/BREASTCA/frame.html</a>). Trials coded with the key words 'early breast cancer', 'locally advanced breast cancer', 'surgery', 'mammoplasty', 'axilla', 'fibrin tissue adhesive', 'lymph node excision', 'mastectomy', 'modified radical mastectomy', 'MRM', 'postoperative complications', 'seroma', 'tissue adhesives', 'fibrin glue', 'fibrin adhesive glue', 'fibrin glue instillation', 'breast surgery', 'breast conserving surgery', 'lumpectomy', 'quadrantectomy', 'oncoplastic breast surgery', axillary sampling', 'axillary sentinel node biopsy', 'breast reconstruction' and 'seroma prevention therapies' were extracted and considered for inclusion in the review. </p> </li> <li> <p>MEDLINE (via OvidSP) (to 9 December 2011). See <a href="./appendices#CD009557-sec-0090">Appendix 1</a> for the search strategy. </p> </li> <li> <p>EMBASE (via Embase.com) (to 9 December 2011). See <a href="./appendices#CD009557-sec-0091">Appendix 2</a> for the search strategy. </p> </li> <li> <p>LILACS via Virtual Health Library (VHL ‐ <a href="http://bases.bireme.br/cgi-bin/wxislind.exe/iah/online/" target="_blank">bases.bireme.br/cgi-bin/wxislind.exe/iah/online/</a>) (to 22 October 2012). See <a href="./appendices#CD009557-sec-0092">Appendix 3</a> for search strategy. </p> </li> <li> <p>SCI‐E via Web Of Science (to 22 October 2012). See <a href="./appendices#CD009557-sec-0093">Appendix 4</a> for search strategy. </p> </li> <li> <p>The World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) search portal (<a href="http://apps.who.int/trialsearch/Default.aspx" target="_blank">apps.who.int/trialsearch/Default.aspx</a>) (to 9 December 2011). See <a href="./appendices#CD009557-sec-0094">Appendix 5</a> for the search strategy. </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov/ct2/home" target="_blank">clinicaltrials.gov/ct2/home</a>, to 22 October 2012) . See <a href="./appendices#CD009557-sec-0095">Appendix 6</a> for the search strategy. </p> </li> <li> <p>CENTRAL (Issue 1). See <a href="./appendices#CD009557-sec-0096">Appendix 7</a> for the search strategy. </p> </li> </ul> </p> <p>A filter for identifying relevant study designs that is recommended by The Cochrane Collaboration (<a href="./references#CD009557-bbs2-0053" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>) was used to filter out irrelevant studies in MEDLINE and EMBASE. </p> </section> <section id="CD009557-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We searched the references from the included studies to identify further trials. The 'related article' function of MEDLINE was also searched thoroughly in order to identify additional studies. We attempted to gather information on all published, unpublished and ongoing trials from all possible data sources. In addition, breast cancer experts, breast surgeons, breast care nurses and pharmaceutical companies involved in the provision of necessary materials were contacted and asked to provide details of outstanding clinical trials or any relevant unpublished reports. The international societies of breast surgery (British Association of Surgical Oncology, European Association of Surgical Oncology, Association of Breast Surgeons, etc.) and oncoplastic breast surgery (British Association of Plastic Reconstructive and Aesthetic Surgeons) were contacted and asked to provide information on any unpublished studies. </p> </section> </section> <section id="CD009557-sec-0026"> <h3 class="title" id="CD009557-sec-0026">Data collection and analysis</h3> <section id="CD009557-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Studies were selected according to predefined inclusion criteria. The studies identified through searching the electronic databases were independently screened by two review authors (MSS and KHH). Each title and abstract was scanned and, if this was inconclusive, the full copy of the article was retrieved and read. Any disagreements regarding study eligibility were resolved by discussion and, if necessary, with the third and fourth review authors (IFR and RB). The excluded studies were recorded in the '<a href="./references#CD009557-sec-0107" title="">Characteristics of excluded studies</a>' table with details of the reasons for their exclusion. </p> </section> <section id="CD009557-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Data were collected on a Microsoft Excel spread sheet by three review authors (MSS, KHH, IFR) working independently, and confirmed by the fourth review author (RB). The conflict about data and recording was resolved by mutual agreement among all authors. We conducted this systematic review according to the protocol and the recommendations in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009557-bbs2-0053" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). We recorded the inclusion and exclusion criteria in each trial that fulfil our criteria for inclusion. In order to check for adequacy and the quality of included trials, we scored them according to the published guidelines of Jadad et al and Chalmers et al (<a href="./references#CD009557-bbs2-0030" title="ChalmersTC , Smith H Jr, BlackburnB , SilvermanB , SchroederB , ReitmanD , et al. A method for assessing the quality of a randomized control trial. Controlled Clinical Trials1981;2(1):31-49.">Chalmers 1981</a>; <a href="./references#CD009557-bbs2-0056" title="JadadAR , MooreRA , CarrollD , JenkinsonC , ReynoldsDJ , GavaghanDJ , et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?Controlled Clinical Trials1996;17(1):1-12.">Jadad 1996</a>). For those studies with more than one publication, we extracted the data from all publications but considered the final or updated version of each study as the primary reference. </p> <p>The following details on methods were extracted:</p> <p> <ul id="CD009557-list-0005"> <li> <p>operation technique;</p> </li> <li> <p>use of prophylactic antibiotics;</p> </li> <li> <p>type of fibrin used;</p> </li> <li> <p>perioperative untoward events;</p> </li> <li> <p>postoperative untoward events;</p> </li> <li> <p>measuring scales of different variables;</p> </li> <li> <p>information regarding the BMI status of participants and extent of axillary surgery, for example axillary sampling, axillary sentinel node biopsy and axillary dissection of level I, II and III; and </p> </li> <li> <p>data on participants with advanced malignancy, renal failure, heart failure, liver failure, malnutrition and conditions that may contribute to body fluid retention. </p> </li> </ul> </p> <p>The following data on randomisation and blinding procedures were extracted:</p> <p> <ul id="CD009557-list-0006"> <li> <p>number of randomised participants;</p> </li> <li> <p>number of participants not randomised and reasons for their non‐randomisation;</p> </li> <li> <p>exclusion after randomisation;</p> </li> <li> <p>drop‐outs;</p> </li> <li> <p>blinding of participants and observers;</p> </li> <li> <p>intention‐to‐treat (ITT) analysis;</p> </li> <li> <p>internal validity;</p> </li> <li> <p>external validity; and</p> </li> <li> <p>power calculation.</p> </li> </ul> </p> </section> <section id="CD009557-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We defined the methodological quality as the confidence that we can have the design of the study as its reporting restricted the bias in the intervention comparison (<a href="./references#CD009557-bbs2-0030" title="ChalmersTC , Smith H Jr, BlackburnB , SilvermanB , SchroederB , ReitmanD , et al. A method for assessing the quality of a randomized control trial. Controlled Clinical Trials1981;2(1):31-49.">Chalmers 1981</a>; <a href="./references#CD009557-bbs2-0053" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>; <a href="./references#CD009557-bbs2-0056" title="JadadAR , MooreRA , CarrollD , JenkinsonC , ReynoldsDJ , GavaghanDJ , et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?Controlled Clinical Trials1996;17(1):1-12.">Jadad 1996</a>; <a href="./references#CD009557-bbs2-0066" title="MoherD , PhamB , JonesA , CookDJ , JadadAR , MoherM , et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?Lancet1998;352:609-13.">Moher 1998</a>). We also looked for power calculations and the strength of the trial in order to score it precisely and accurately. Due to the risk of overestimating intervention effects in randomised trials with inadequate methodological quality (<a href="./references#CD009557-bbs2-0030" title="ChalmersTC , Smith H Jr, BlackburnB , SilvermanB , SchroederB , ReitmanD , et al. A method for assessing the quality of a randomized control trial. Controlled Clinical Trials1981;2(1):31-49.">Chalmers 1981</a>; <a href="./references#CD009557-bbs2-0053" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>; <a href="./references#CD009557-bbs2-0056" title="JadadAR , MooreRA , CarrollD , JenkinsonC , ReynoldsDJ , GavaghanDJ , et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?Controlled Clinical Trials1996;17(1):1-12.">Jadad 1996</a>; <a href="./references#CD009557-bbs2-0057" title="KjaergardLL , VillumsenJ , GluudC . Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine2001;135:982-9.">Kjaergard 2001</a>; <a href="./references#CD009557-bbs2-0081" title="SchulzKF , ChalmersI , AltmanDG , GrimesDA , DoréCJ . The methodologic quality of randomization as assessed from reports of trials in specialist and general medical journals. The Online Journal of Current Clinical Trials1995;197:81.">Schulz 1995</a>), we assessed the influence of the methodological quality on the review findings. In short, our group used the full Cochrane 'Risk of bias' tool in addition to the guidelines published by Chalmers et al and Jadad et al (<a href="./references#CD009557-bbs2-0030" title="ChalmersTC , Smith H Jr, BlackburnB , SilvermanB , SchroederB , ReitmanD , et al. A method for assessing the quality of a randomized control trial. Controlled Clinical Trials1981;2(1):31-49.">Chalmers 1981</a>; <a href="./references#CD009557-bbs2-0056" title="JadadAR , MooreRA , CarrollD , JenkinsonC , ReynoldsDJ , GavaghanDJ , et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?Controlled Clinical Trials1996;17(1):1-12.">Jadad 1996</a>). </p> <section id="CD009557-sec-0030"> <h5 class="title">Generation of the allocation sequence</h5> <p> <ul id="CD009557-list-0007"> <li> <p>Low, if the allocation sequence was generated by a computer or random number table. Drawing of lots, tossing of a coin, shuffling of cards or throwing dice were considered as adequate if a person who was not otherwise involved in the recruitment of participants performed the procedure. </p> </li> <li> <p>Unclear, if the trial was described as randomised but the method used for the allocation sequence generation was not described. </p> </li> <li> <p>Inadequate, if a system involving dates, names or admittance numbers was used for the allocation of participants. These studies are known as quasi‐randomised and were excluded from the present review when assessing beneficial effects of the intervention. </p> </li> </ul> </p> </section> <section id="CD009557-sec-0031"> <h5 class="title">Allocation concealment</h5> <p> <ul id="CD009557-list-0008"> <li> <p>Low, if the allocation of participants involved a central independent unit, an on‐site locked computer or sealed envelopes. </p> </li> <li> <p>Unclear, if the trial was described as randomised but the method used to conceal the allocation was not described. </p> </li> <li> <p>High, if the allocation sequence was known to the investigators who assigned participants or if the study was quasi‐randomised. </p> </li> </ul> </p> </section> <section id="CD009557-sec-0032"> <h5 class="title">Double blinding or masking</h5> <p> <ul id="CD009557-list-0009"> <li> <p>Low, if the trial was described as double blind and the method of blinding was described.</p> </li> <li> <p>Unclear, if the trial was described as double blind but the method of blinding was not described. </p> </li> <li> <p>Not performed, if there was no blinding at all.</p> </li> </ul> </p> </section> <section id="CD009557-sec-0033"> <h5 class="title">Follow‐up and intention‐to‐treat analysis</h5> <p> <ul id="CD009557-list-0010"> <li> <p>Low, if the numbers and reasons for drop‐outs and withdrawals in all intervention groups were described, or if it was specified that there were no drop‐outs or withdrawals. </p> </li> <li> <p>Unclear, if the report gave the impression that there had been no drop‐outs or withdrawals but this was not specifically stated. </p> </li> <li> <p>High, if the number or reasons for drop‐outs and withdrawals were not described.</p> </li> </ul> </p> </section> </section> <section id="CD009557-sec-0034"> <h4 class="title">Measures of treatment effect</h4> <p>The risk ratio (RR) with a 95% confidence interval (CI) was calculated for binary data variables such as the incidence of seroma, mortality, morbidity and re‐intervention rate. We reported the RRs of treatment effects for responses so that RRs less than 1.0 favour FG and RRs greater than 1.0 favour no‐fibrin glue (NFG).The standardised mean difference (SMD) with a 95% CI was calculated for continuous data variables, such as seroma volume, hospital stay, cost analysis and measurement of HRQoL. If the mean values were not available for continuous outcomes, median values were used for the purpose of the meta‐analysis. We estimated the mean from the median, range and sample size according to the method recommended by Hozo et al (<a href="./references#CD009557-bbs2-0055" title="HozoSP , DjulbegovicB , HozoI . Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology2005;20(5):13.">Hozo 2005</a>). If the standard deviation was not available, we calculated it according to the guidelines of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (Chapter 16.1.3) (<a href="./references#CD009557-bbs2-0053" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). This involved the assumption that both groups had the same variance, which may not be true. </p> </section> <section id="CD009557-sec-0035"> <h4 class="title">Unit of analysis issues</h4> <p>RR for binary data and SMD for continuous data were used to express the combined outcome. Mean values ± standard deviations were used for the statistical analysis. If mean values were not reported, median values were used according to the formula already described in the <a href="#CD009557-sec-0015">Methods</a> section. If the standard deviation was not reported, it was estimated either from the range value or from the P value as described in the <a href="#CD009557-sec-0015">Methods</a> section. </p> </section> <section id="CD009557-sec-0036"> <h4 class="title">Dealing with missing data</h4> <p>We contacted the first author of a study via personal communication in order to retrieve missing data. If further information was required from any source, we contacted all relevant people involved in the running of that published trial. If missing data could not be obtained, and the particular trial did not score according to our inclusion criteria, we excluded the trial giving reasons for its exclusion in the <a href="./references#CD009557-sec-0107" title="">Characteristics of excluded studies</a> table. We looked at the missing data on an outcome by outcome basis. </p> </section> <section id="CD009557-sec-0037"> <h4 class="title">Assessment of heterogeneity</h4> <p>Heterogeneity was explored using the Chi<sup>2</sup> test, with significance set at P value &lt; 0.05, and it was quantified using the I<sup>2</sup> statistic (<a href="./references#CD009557-bbs2-0052" title="HigginsJP , ThompsonSG . Quantifying heterogeneity in a meta-analysis. Statistics in Medicine2002;21:1539-58.">Higgins 2002</a>), with a maximum value of 30% identifying low heterogeneity (<a href="./references#CD009557-bbs2-0052" title="HigginsJP , ThompsonSG . Quantifying heterogeneity in a meta-analysis. Statistics in Medicine2002;21:1539-58.">Higgins 2002</a>; <a href="./references#CD009557-bbs2-0053" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). We also inspected the graphical representation of the data. In case of heterogeneity, we reported the results of random‐effects model. </p> </section> <section id="CD009557-sec-0038"> <h4 class="title">Assessment of reporting biases</h4> <p>We employed the recommendations on testing for funnel plot asymmetry and discussed plot asymmetry, possibly as a consequence of reporting bias, as outlined in Section 10.4.3.1 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009557-bbs2-0053" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). </p> </section> <section id="CD009557-sec-0039"> <h4 class="title">Data synthesis</h4> <p>The random‐effects model (<a href="./references#CD009557-bbs2-0042" title="DerSimonianR , LairdN . Meta-analysis in clinical trials. Controlled Clinical Trials1986;7:177-88.">DerSimonian 1986</a>), as well as the fixed‐effect model (<a href="./references#CD009557-bbs2-0040" title="DeMetsDL . Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine1987;6:341-50.">DeMets 1987</a>), were used to calculate the combined outcome in cases of both binary and continuous variables. For dichotomous outcomes, the Mantel‐Haenszel method was used for the calculation of RR under the fixed‐effect and random‐effects models (<a href="./references#CD009557-bbs2-0044" title="EggerM , SmithGD , AltmanDG . Systematic reviews in healthcare. 1 edition. Vol. 1. London: BMJ Publishers, 2006.">Egger 2006</a>). In a sensitivity analysis, 0.5 was added to each cell frequency for trials in which no event occurred in either the treatment or control group, according to the recommended method (<a href="./references#CD009557-bbs2-0038" title="DeeksJJ , AltmanDG , BradburnMJ . Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Matthias Egger, George Davey Smith, Douglas G Altman, editors(s). Systemic Reviews in Health Care: Meta-Analysis in Context. 2nd edition. Vol. 1. London: BMJ Publishers, 2001:285-312.">Deeks 2001</a>). The estimate of the difference between groups was pooled, depending upon the effect weights in results determined by each trial estimate variance. The forest plot was used for the graphical display of the results from the meta‐analyses. The square around the estimate stood for the accuracy of the estimation (sample size) and the horizontal line represented the 95% CI. The statistical analysis was performed by MSS and confirmed by KHH and IFR. The software package Review Manager 5.1.2 (<a href="./references#CD009557-bbs2-0073" title="The Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.">RevMan 2011</a>), provided by The Cochrane Collaboration was used for analysis. </p> <p>A <a href="./full#CD009557-tbl-0001">summary of findings Table 1</a> was developed to assess the overall quality of the body of evidence. </p> </section> <section id="CD009557-sec-0040"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Based on the duration of follow‐up there were insufficient data to perform subgroup analyses. We performed the subgroup analysis on trials in breast surgery and breast plus axillary surgery to find out if there was any difference depending upon the site of surgery for breast cancer. </p> </section> <section id="CD009557-sec-0041"> <h4 class="title">Sensitivity analysis</h4> <p>When adequate data were available, we performed sensitivity analysis to assess the robustness of our results by repeating the analysis with the following adjustments: </p> <p> <ul id="CD009557-list-0011"> <li> <p>repeating the analysis excluding studies with high risk of bias.</p> </li> </ul> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009557-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009557-sec-0042"></div> <section id="CD009557-sec-0043"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD009557-sec-0106" title="">Characteristics of included studies</a>. </p> <section id="CD009557-sec-0044"> <h4 class="title">Results of the search</h4> <p>We searched four electronic databases using MeSH headings mentioned in the <a href="#CD009557-sec-0015">Methods</a> section and search strategies explained in <a href="./appendices#CD009557-sec-0090">Appendix 1</a>, <a href="./appendices#CD009557-sec-0091">Appendix 2</a> and <a href="./appendices#CD009557-sec-0092">Appendix 3</a>, yielding 119 potentially relevant records. The CENTRAL database search produced 23 relevant trials while MEDLINE, EMBASE and the WHO ICTRP electronic databases yielded 53, 31 and 12 relevant trials potentially suitable for inclusion, respectively. Further screening of these potentially relevant studies was performed and outlined in the PRISMA flow chart (see: <a href="#CD009557-fig-0001">Figure 1</a>). Eighteen RCTs encompassing 1252 participants undergoing breast and axillary surgery for breast cancer were retrieved from the electronic databases (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>; <a href="./references#CD009557-bbs2-0002" title="DinsmoreRC , HarrisJA , GustafsonRJ . Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. American Surgeon2000;66:982-5. ">Dinsmore 2000</a>; <a href="./references#CD009557-bbs2-0003" title="El-NakeebA . Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study. The Breast Journal2009;15:671-2. ">El‐Nakeeb 2009</a>; <a href="./references#CD009557-bbs2-0004" title="GillyFN , FrançoisY , Sayag-BeaujardAC , GlehenO , BrachetA , VignalJ . Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. European Surgical Research1998;30:439-43. ">Gilly 1998</a>; <a href="./references#CD009557-bbs2-0005" title="Gioffrè FlorioMA , MezzasalmaF , ManganaroT , PakravananH , CogliandoloA . The use of fibrin glue in the surgery of breast carcinoma. Il Giornale di Chirurgia1993;14:239-41. ">Gioffrè Florio 1993</a>; <a href="./references#CD009557-bbs2-0006" title="JainPK , SowdiR , AndersonAD , MacFieJ . Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. The British Journal of Surgery2004;91:54-60. ">Jain 2004</a>; <a href="./references#CD009557-bbs2-0007" title="JohnsonL , CusickTE , HelmerSD , OslandJS . Influence of fibrin glue on seroma formation after breast surgery. American Journal of Surgery2005;189:319-23. ">Johnson 2005</a>; <a href="./references#CD009557-bbs2-0008" title="KoE , HanW , ChoJ , LeeJW , KangSY , JungSY , et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. Journal of Korean Medical Science2009;24:92-6. ">Ko 2009</a>; <a href="./references#CD009557-bbs2-0009" title="LangerS , GuentherJM , DiFronzoLA . Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?American Surgeon2003;69:77-81. ">Langer 2003</a>; <a href="./references#CD009557-bbs2-0010" title="MooreMM , NguyenDH , SpotnitzWD . Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. American Surgeon1997;63:97-102. ">Moore 1997</a>; <a href="./references#CD009557-bbs2-0011" title="MooreM , Burak WE Jr, NelsonE , KearneyT , SimmonsR , MayersL , et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. Journal of the American College of Surgeons2001;192:591-9. ">Moore 2001</a>; <a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>; <a href="./references#CD009557-bbs2-0013" title="RuggieroR , ProcacciniE , GiliS , CremoneC , ParmeggianiD , ConzoG , et al. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. Il Giornale di Chirurgia2009;30:306-10. ">Ruggiero 2009</a>; <a href="./references#CD009557-bbs2-0014" title="Segura-CastilloJL , Estrada-RiveraO , Castro-CervantesJM , Cortés-FloresAO , Velázquez-RamírezGA , González-OjedaA . Reduction of lymphatic drainage posterior to modified radical mastectomy with the application of fibrin glue. Cirugia y Circujanos2005;73(5):345-50. ">Segura‐Castillo 2005</a>; <a href="./references#CD009557-bbs2-0015" title="TasinatoR , GodinaM , GriggioL , Da DaltGF , ScuderiA , ReschiglianE . Prevention of axillary seromas in patients who underwent limphadenectomy for breast cancer. Acta Chirurgica Italica1993;49(1):479-84. ">Tasinato 1993</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>). </p> <div class="figure" id="CD009557-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA flow chart showing trial selection methodology." data-id="CD009557-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA flow chart showing trial selection methodology.</p> </div> </div> </div> </section> <section id="CD009557-sec-0045"> <h4 class="title">Included studies</h4> <p>We identified 18 eligible RCTs encompassing 1252 participants undergoing breast and axillary surgery for breast cancer (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>; <a href="./references#CD009557-bbs2-0002" title="DinsmoreRC , HarrisJA , GustafsonRJ . Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. American Surgeon2000;66:982-5. ">Dinsmore 2000</a>; <a href="./references#CD009557-bbs2-0003" title="El-NakeebA . Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study. The Breast Journal2009;15:671-2. ">El‐Nakeeb 2009</a>; <a href="./references#CD009557-bbs2-0004" title="GillyFN , FrançoisY , Sayag-BeaujardAC , GlehenO , BrachetA , VignalJ . Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. European Surgical Research1998;30:439-43. ">Gilly 1998</a>; <a href="./references#CD009557-bbs2-0005" title="Gioffrè FlorioMA , MezzasalmaF , ManganaroT , PakravananH , CogliandoloA . The use of fibrin glue in the surgery of breast carcinoma. Il Giornale di Chirurgia1993;14:239-41. ">Gioffrè Florio 1993</a>; <a href="./references#CD009557-bbs2-0006" title="JainPK , SowdiR , AndersonAD , MacFieJ . Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. The British Journal of Surgery2004;91:54-60. ">Jain 2004</a>; <a href="./references#CD009557-bbs2-0007" title="JohnsonL , CusickTE , HelmerSD , OslandJS . Influence of fibrin glue on seroma formation after breast surgery. American Journal of Surgery2005;189:319-23. ">Johnson 2005</a>; <a href="./references#CD009557-bbs2-0008" title="KoE , HanW , ChoJ , LeeJW , KangSY , JungSY , et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. Journal of Korean Medical Science2009;24:92-6. ">Ko 2009</a>; <a href="./references#CD009557-bbs2-0009" title="LangerS , GuentherJM , DiFronzoLA . Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?American Surgeon2003;69:77-81. ">Langer 2003</a>; <a href="./references#CD009557-bbs2-0010" title="MooreMM , NguyenDH , SpotnitzWD . Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. American Surgeon1997;63:97-102. ">Moore 1997</a>; <a href="./references#CD009557-bbs2-0011" title="MooreM , Burak WE Jr, NelsonE , KearneyT , SimmonsR , MayersL , et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. Journal of the American College of Surgeons2001;192:591-9. ">Moore 2001</a>; <a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>; <a href="./references#CD009557-bbs2-0013" title="RuggieroR , ProcacciniE , GiliS , CremoneC , ParmeggianiD , ConzoG , et al. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. Il Giornale di Chirurgia2009;30:306-10. ">Ruggiero 2009</a>; <a href="./references#CD009557-bbs2-0014" title="Segura-CastilloJL , Estrada-RiveraO , Castro-CervantesJM , Cortés-FloresAO , Velázquez-RamírezGA , González-OjedaA . Reduction of lymphatic drainage posterior to modified radical mastectomy with the application of fibrin glue. Cirugia y Circujanos2005;73(5):345-50. ">Segura‐Castillo 2005</a>; <a href="./references#CD009557-bbs2-0015" title="TasinatoR , GodinaM , GriggioL , Da DaltGF , ScuderiA , ReschiglianE . Prevention of axillary seromas in patients who underwent limphadenectomy for breast cancer. Acta Chirurgica Italica1993;49(1):479-84. ">Tasinato 1993</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>). There were 625 participants in the FG group and 627 participants in the NFG group. Recruited participants in the included trials had not had clinical, biochemical and radiological evidence of metastatic breast carcinoma. All of the included studies were small, with sample sizes ranging from 21 (<a href="./references#CD009557-bbs2-0010" title="MooreMM , NguyenDH , SpotnitzWD . Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. American Surgeon1997;63:97-102. ">Moore 1997</a>) to 159 (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>) participants. All participants were considered to have early breast cancer requiring mastectomy, sector mastectomy, MRM, wide local excision, axillary dissection and axillary procedure alone or as an adjunctive procedure. Preoperative risk stratification for poor wound healing and wound breakdown was not reported; however, the majority of trials did not recruit people with multiple comorbidities potentially contributing to the wound complications. None of the reported trials were multicentre. </p> <p>Cipolla et al recruited 159 participants undergoing MRM and quadrantectomy (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>). Eighty people were in the FG group and 79 people were in the NFG group. There were no preoperative or postoperative confounding interventions reported in this trial apart from the allocated application of FG in the relevant arm of the trial. This trial was run in Italy. The primary outcome was mean duration of axillary drainage and the secondary outcomes included the incidence of seroma, mean total drainage volume, mean seroma aspirate volume, wound infection, complications and mean number of seroma aspirations. </p> <p>Dinsmore et al recruited 27 participants undergoing MRM (<a href="./references#CD009557-bbs2-0002" title="DinsmoreRC , HarrisJA , GustafsonRJ . Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. American Surgeon2000;66:982-5. ">Dinsmore 2000</a>). Fourteen people were in the FG group and 13 people were in the NFG group. There were no preoperative or postoperative confounding interventions reported in this trial apart from the allocated application of FG in the relevant arm of the trial. This trial was run in the USA. The primary outcome was incidence of seroma and the secondary outcomes included total volume of seroma, duration of axillary drainage volume and wound complications. </p> <p>El‐Nakeeb et al recruited 50 participants undergoing MRM (<a href="./references#CD009557-bbs2-0003" title="El-NakeebA . Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study. The Breast Journal2009;15:671-2. ">El‐Nakeeb 2009</a>). Twenty‐five people were in the FG group and 25 people were in the NFG group. There were no preoperative or postoperative confounding interventions reported in this trial apart from the allocated application of FG in the relevant arm of the trial. This trial was run in Egypt. The primary outcome was seroma incidence and the secondary outcomes included total volume of seroma, duration of drainage and wound complications. </p> <p>Gilly et al recruited 108 participants undergoing MRM (<a href="./references#CD009557-bbs2-0004" title="GillyFN , FrançoisY , Sayag-BeaujardAC , GlehenO , BrachetA , VignalJ . Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. European Surgical Research1998;30:439-43. ">Gilly 1998</a>). Fifty people were in the FG group and 58 people were in the NFG group. The postoperative local pressure dressing and shoulder physiotherapy were confounding interventions reported in this trial. This trial was run in France. The primary outcome was seroma incidence and the secondary outcomes included total volume of seroma, length of hospital stay and wound complications. </p> <p>Gioffre Florio et al recruited 24 participants undergoing MRM, wide local excision and axillary dissection (<a href="./references#CD009557-bbs2-0005" title="Gioffrè FlorioMA , MezzasalmaF , ManganaroT , PakravananH , CogliandoloA . The use of fibrin glue in the surgery of breast carcinoma. Il Giornale di Chirurgia1993;14:239-41. ">Gioffrè Florio 1993</a>). Twelve people were in the FG group and 12 people were in the NFG group. The perioperative drain insertion under the skin flaps was one confounding intervention reported in this trial apart from the allocated application of FG in the relevant arm of the trial. This trial was run in Italy. The primary outcome was seroma incidence and the secondary outcome included mean volume of seroma. </p> <p>Jain et al recruited 87 participants undergoing MRM, segmentectomy and axillary dissection (<a href="./references#CD009557-bbs2-0006" title="JainPK , SowdiR , AndersonAD , MacFieJ . Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. The British Journal of Surgery2004;91:54-60. ">Jain 2004</a>). Twenty‐nine people were in the FG group and 58 people were in the NFG group. The postoperative local pressure dressing and drain insertion were confounding interventions reported in this trial apart from the allocated application of the FG in the relevant arm of the trial. This trial was run in the UK. The primary outcome was seroma incidence and the secondary outcomes included mean volume of seroma, wound infection, postoperative complications and length of hospital stay. </p> <p>Johnson et al recruited 82 participants undergoing MRM, wide local excision and axillary dissection (<a href="./references#CD009557-bbs2-0007" title="JohnsonL , CusickTE , HelmerSD , OslandJS . Influence of fibrin glue on seroma formation after breast surgery. American Journal of Surgery2005;189:319-23. ">Johnson 2005</a>). Thirty‐eight people were in the FG group and 44 people were in the NFG group. There was no confounding intervention reported in this trial. This trial was run in the USA. The primary outcome was seroma incidence and the secondary outcomes included mean volume of seroma, wound infection, postoperative complications and length of hospital stay. </p> <p>Ko et al recruited 100 participants undergoing lumpectomy (<a href="./references#CD009557-bbs2-0008" title="KoE , HanW , ChoJ , LeeJW , KangSY , JungSY , et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. Journal of Korean Medical Science2009;24:92-6. ">Ko 2009</a>). Fifty people were in the FG group and 50 people were in the NFG group. The postoperative local pressure dressing was a confounding intervention reported in this trial apart from the allocated application of FG in the relevant arm of the trial. This trial was run in South Korea. The primary outcome was seroma incidence and the secondary outcomes included mean volume of seroma, total volume of seroma, mean number of drainage days, wound infection and postoperative complications. </p> <p>Langer et al recruited 55 participants undergoing lumpectomy (<a href="./references#CD009557-bbs2-0009" title="LangerS , GuentherJM , DiFronzoLA . Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?American Surgeon2003;69:77-81. ">Langer 2003</a>). Twenty‐six people were in the FG group and 29 people were in the NFG group. The postoperative reduced shoulder mobilisation was a confounding intervention reported in this trial. This trial was run in the USA. The primary outcome was seroma incidence and the secondary outcomes included total volume of seroma, mean number of drainage days and wound infection. </p> <p>Moore et al recruited 21 participants undergoing MRM (<a href="./references#CD009557-bbs2-0010" title="MooreMM , NguyenDH , SpotnitzWD . Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. American Surgeon1997;63:97-102. ">Moore 1997</a>). Eleven people were in the FG group and 10 people were in the NFG group. There was no postoperative confounding intervention in this trial. This trial was run in the USA. The primary outcome was total volume of seroma and the secondary outcomes included seroma incidence and length of hospital stay. </p> <p>Moore et al recruited 80 participants undergoing MRM and lumpectomy (<a href="./references#CD009557-bbs2-0011" title="MooreM , Burak WE Jr, NelsonE , KearneyT , SimmonsR , MayersL , et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. Journal of the American College of Surgeons2001;192:591-9. ">Moore 2001</a>). Fifty‐nine people were in the FG group and 21 people were in the NFG group. There was no postoperative confounding intervention in this trial. This trial was run in the USA. The primary outcome was seroma incidence and the secondary outcomes included wound infection, length of seroma drainage in days, total seroma volume and postoperative complications. </p> <p>Mustonen et al recruited 40 participants undergoing MRM (<a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>). Nineteen people were in the FG group and 21 people were in the NFG group. The postoperative compression dressing of the thoracic wall was a confounding intervention reported in this trial. This trial was run in Finland. The primary outcome was seroma incidence and the secondary outcomes included total volume of seroma, mean number of drainage days, mean volume of seroma, length of hospital stay and wound infection. </p> <p>Ruggiero et al recruited 90 participants undergoing MRM and quadrantectomy (<a href="./references#CD009557-bbs2-0013" title="RuggieroR , ProcacciniE , GiliS , CremoneC , ParmeggianiD , ConzoG , et al. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. Il Giornale di Chirurgia2009;30:306-10. ">Ruggiero 2009</a>). Forty‐five people were in the FG group and 45 people were in the NFG group. The postoperative compression dressing of the thoracic wall was a confounding intervention reported in this trial. This trial was run in Italy. The primary outcome was seroma incidence and the secondary outcomes included total volume of seroma, postoperative complications and wound infection. </p> <p>Segura‐Castillo et al recruited 45 participants undergoing MRM and axillary dissection (<a href="./references#CD009557-bbs2-0014" title="Segura-CastilloJL , Estrada-RiveraO , Castro-CervantesJM , Cortés-FloresAO , Velázquez-RamírezGA , González-OjedaA . Reduction of lymphatic drainage posterior to modified radical mastectomy with the application of fibrin glue. Cirugia y Circujanos2005;73(5):345-50. ">Segura‐Castillo 2005</a>). Twenty‐two people were in the FG group and 23 people were in the NFG group. There was no postoperative confounding intervention reported in this trial. This trial was run in Mexico. The primary outcome was seroma incidence and the secondary outcomes included mean number of drainage days, postoperative complications and wound infection. </p> <p>Tasinato et al recruited 127 participants undergoing axillary dissection (<a href="./references#CD009557-bbs2-0015" title="TasinatoR , GodinaM , GriggioL , Da DaltGF , ScuderiA , ReschiglianE . Prevention of axillary seromas in patients who underwent limphadenectomy for breast cancer. Acta Chirurgica Italica1993;49(1):479-84. ">Tasinato 1993</a>). Sixty‐six people were in the FG group and 61 people were in the NFG group. The postoperative compression dressing of the thoracic wall was a confounding intervention reported in this trial. This trial was run in Italy. The primary outcome was mean seroma volume and secondary outcomes included seroma incidence, drainage days, postoperative complications and wound infection. </p> <p>Uden et al recruited 68 participants undergoing MRM (<a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>). Thirty‐six people were in the FG group and 32 people were in the NFG group. The postoperative compression dressing of the thoracic wall was a confounding intervention reported in this trial. This trial was run in Sweden. The primary outcome was the incidence of seroma and secondary outcomes included mean seroma volume, total volume of seroma, drainage days, postoperative complications, length of hospital stay and wound infection. </p> <p>Ulusoy et al recruited 54 participants undergoing MRM (<a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>). Twenty‐seven people were in the FG group and 27 people were in the NFG group. There was no postoperative confounding intervention reported in this trial. This trial was run in Turkey. The primary outcome was the incidence of seroma and secondary outcomes included mean seroma volume, total volume of seroma, drainage days and wound infection. </p> <p>Vaxman et al recruited 40 participants undergoing MRM (<a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>). Twenty people were in the FG group and 20 people were in the NFG group. The postoperative compression dressing of the thoracic wall and shoulder physiotherapy were confounding interventions reported in this trial. This trial was run in France. The primary outcome was the incidence of seroma and secondary outcomes included mean seroma volume, total volume of seroma, drainage days, length of hospital stay and postoperative complications. </p> </section> <section id="CD009557-sec-0046"> <h4 class="title">Excluded studies</h4> <p>See: <a href="./references#CD009557-sec-0107" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD009557-sec-0047"> <h3 class="title">Risk of bias in included studies</h3> <section id="CD009557-sec-0048"> <h4 class="title">Allocation</h4> <p>The random sequence generation and allocation concealment of the recruited participants in these RCTs were not reported precisely. In good‐quality RCTs, the optimum sequence generation was reported in four trials only where participants were randomly distributed to the control or experimental group according to computer‐generated codes, web‐based sequences and lottery‐based systems (<a href="./references#CD009557-bbs2-0006" title="JainPK , SowdiR , AndersonAD , MacFieJ . Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. The British Journal of Surgery2004;91:54-60. ">Jain 2004</a>; <a href="./references#CD009557-bbs2-0008" title="KoE , HanW , ChoJ , LeeJW , KangSY , JungSY , et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. Journal of Korean Medical Science2009;24:92-6. ">Ko 2009</a>; <a href="./references#CD009557-bbs2-0010" title="MooreMM , NguyenDH , SpotnitzWD . Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. American Surgeon1997;63:97-102. ">Moore 1997</a>; <a href="./references#CD009557-bbs2-0011" title="MooreM , Burak WE Jr, NelsonE , KearneyT , SimmonsR , MayersL , et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. Journal of the American College of Surgeons2001;192:591-9. ">Moore 2001</a>). We classified an additional four RCTs with low risk of bias because the technique of randomisation was random numbers based (<a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>; <a href="./references#CD009557-bbs2-0014" title="Segura-CastilloJL , Estrada-RiveraO , Castro-CervantesJM , Cortés-FloresAO , Velázquez-RamírezGA , González-OjedaA . Reduction of lymphatic drainage posterior to modified radical mastectomy with the application of fibrin glue. Cirugia y Circujanos2005;73(5):345-50. ">Segura‐Castillo 2005</a>; <a href="./references#CD009557-bbs2-0015" title="TasinatoR , GodinaM , GriggioL , Da DaltGF , ScuderiA , ReschiglianE . Prevention of axillary seromas in patients who underwent limphadenectomy for breast cancer. Acta Chirurgica Italica1993;49(1):479-84. ">Tasinato 1993</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>). Ten trials were classified with high risk of bias due to the absence of reporting the randomisation technique and kind of allocation concealment (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>; <a href="./references#CD009557-bbs2-0002" title="DinsmoreRC , HarrisJA , GustafsonRJ . Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. American Surgeon2000;66:982-5. ">Dinsmore 2000</a>; <a href="./references#CD009557-bbs2-0003" title="El-NakeebA . Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study. The Breast Journal2009;15:671-2. ">El‐Nakeeb 2009</a>; <a href="./references#CD009557-bbs2-0004" title="GillyFN , FrançoisY , Sayag-BeaujardAC , GlehenO , BrachetA , VignalJ . Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. European Surgical Research1998;30:439-43. ">Gilly 1998</a>; <a href="./references#CD009557-bbs2-0005" title="Gioffrè FlorioMA , MezzasalmaF , ManganaroT , PakravananH , CogliandoloA . The use of fibrin glue in the surgery of breast carcinoma. Il Giornale di Chirurgia1993;14:239-41. ">Gioffrè Florio 1993</a>; <a href="./references#CD009557-bbs2-0007" title="JohnsonL , CusickTE , HelmerSD , OslandJS . Influence of fibrin glue on seroma formation after breast surgery. American Journal of Surgery2005;189:319-23. ">Johnson 2005</a>; <a href="./references#CD009557-bbs2-0009" title="LangerS , GuentherJM , DiFronzoLA . Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?American Surgeon2003;69:77-81. ">Langer 2003</a>; <a href="./references#CD009557-bbs2-0013" title="RuggieroR , ProcacciniE , GiliS , CremoneC , ParmeggianiD , ConzoG , et al. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. Il Giornale di Chirurgia2009;30:306-10. ">Ruggiero 2009</a>; <a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>). </p> </section> <section id="CD009557-sec-0049"> <h4 class="title">Blinding</h4> <p>Blinding of the operating surgeon was not possible due to the nature of the RCTs. However, blinding of the trial participants and outcome assessors was neither investigated nor reported adequately by the majority of the included studies. RCTs with an optimum blinding approach was adopted in only five studies (<a href="./references#CD009557-bbs2-0006" title="JainPK , SowdiR , AndersonAD , MacFieJ . Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. The British Journal of Surgery2004;91:54-60. ">Jain 2004</a>; <a href="./references#CD009557-bbs2-0008" title="KoE , HanW , ChoJ , LeeJW , KangSY , JungSY , et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. Journal of Korean Medical Science2009;24:92-6. ">Ko 2009</a>; <a href="./references#CD009557-bbs2-0010" title="MooreMM , NguyenDH , SpotnitzWD . Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. American Surgeon1997;63:97-102. ">Moore 1997</a>; <a href="./references#CD009557-bbs2-0011" title="MooreM , Burak WE Jr, NelsonE , KearneyT , SimmonsR , MayersL , et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. Journal of the American College of Surgeons2001;192:591-9. ">Moore 2001</a>; <a href="./references#CD009557-bbs2-0014" title="Segura-CastilloJL , Estrada-RiveraO , Castro-CervantesJM , Cortés-FloresAO , Velázquez-RamírezGA , González-OjedaA . Reduction of lymphatic drainage posterior to modified radical mastectomy with the application of fibrin glue. Cirugia y Circujanos2005;73(5):345-50. ">Segura‐Castillo 2005</a>). Therefore, based on the blinding technique, 13 RCTs were classified as inadequate with a high risk of bias (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>; <a href="./references#CD009557-bbs2-0002" title="DinsmoreRC , HarrisJA , GustafsonRJ . Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. American Surgeon2000;66:982-5. ">Dinsmore 2000</a>; <a href="./references#CD009557-bbs2-0003" title="El-NakeebA . Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study. The Breast Journal2009;15:671-2. ">El‐Nakeeb 2009</a>; <a href="./references#CD009557-bbs2-0004" title="GillyFN , FrançoisY , Sayag-BeaujardAC , GlehenO , BrachetA , VignalJ . Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. European Surgical Research1998;30:439-43. ">Gilly 1998</a>; <a href="./references#CD009557-bbs2-0005" title="Gioffrè FlorioMA , MezzasalmaF , ManganaroT , PakravananH , CogliandoloA . The use of fibrin glue in the surgery of breast carcinoma. Il Giornale di Chirurgia1993;14:239-41. ">Gioffrè Florio 1993</a>; <a href="./references#CD009557-bbs2-0007" title="JohnsonL , CusickTE , HelmerSD , OslandJS . Influence of fibrin glue on seroma formation after breast surgery. American Journal of Surgery2005;189:319-23. ">Johnson 2005</a>; <a href="./references#CD009557-bbs2-0009" title="LangerS , GuentherJM , DiFronzoLA . Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?American Surgeon2003;69:77-81. ">Langer 2003</a>; <a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>; <a href="./references#CD009557-bbs2-0013" title="RuggieroR , ProcacciniE , GiliS , CremoneC , ParmeggianiD , ConzoG , et al. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. Il Giornale di Chirurgia2009;30:306-10. ">Ruggiero 2009</a>; <a href="./references#CD009557-bbs2-0015" title="TasinatoR , GodinaM , GriggioL , Da DaltGF , ScuderiA , ReschiglianE . Prevention of axillary seromas in patients who underwent limphadenectomy for breast cancer. Acta Chirurgica Italica1993;49(1):479-84. ">Tasinato 1993</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>). </p> </section> <section id="CD009557-sec-0050"> <h4 class="title">Incomplete outcome data</h4> <p>In judging the risk of bias for incomplete data reporting, we evaluated the primary outcome measure, namely incidence of seroma. We also considered whether an ITT analysis was considered for the primary outcome and missing data were imputed appropriately. We judged that there was a high risk of bias due to the lack of reporting on missing participants recruited in the RCT. RCTs with optimum ITT analysis was adopted in five studies only (<a href="./references#CD009557-bbs2-0006" title="JainPK , SowdiR , AndersonAD , MacFieJ . Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. The British Journal of Surgery2004;91:54-60. ">Jain 2004</a>; <a href="./references#CD009557-bbs2-0008" title="KoE , HanW , ChoJ , LeeJW , KangSY , JungSY , et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. Journal of Korean Medical Science2009;24:92-6. ">Ko 2009</a>; <a href="./references#CD009557-bbs2-0010" title="MooreMM , NguyenDH , SpotnitzWD . Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. American Surgeon1997;63:97-102. ">Moore 1997</a>; <a href="./references#CD009557-bbs2-0011" title="MooreM , Burak WE Jr, NelsonE , KearneyT , SimmonsR , MayersL , et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. Journal of the American College of Surgeons2001;192:591-9. ">Moore 2001</a>; <a href="./references#CD009557-bbs2-0014" title="Segura-CastilloJL , Estrada-RiveraO , Castro-CervantesJM , Cortés-FloresAO , Velázquez-RamírezGA , González-OjedaA . Reduction of lymphatic drainage posterior to modified radical mastectomy with the application of fibrin glue. Cirugia y Circujanos2005;73(5):345-50. ">Segura‐Castillo 2005</a>). Therefore, based on the lack of ITT analysis, 17 RCTs were classified inadequate with high risk of bias (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>; <a href="./references#CD009557-bbs2-0002" title="DinsmoreRC , HarrisJA , GustafsonRJ . Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. American Surgeon2000;66:982-5. ">Dinsmore 2000</a>; <a href="./references#CD009557-bbs2-0003" title="El-NakeebA . Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study. The Breast Journal2009;15:671-2. ">El‐Nakeeb 2009</a>; <a href="./references#CD009557-bbs2-0004" title="GillyFN , FrançoisY , Sayag-BeaujardAC , GlehenO , BrachetA , VignalJ . Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. European Surgical Research1998;30:439-43. ">Gilly 1998</a>; <a href="./references#CD009557-bbs2-0005" title="Gioffrè FlorioMA , MezzasalmaF , ManganaroT , PakravananH , CogliandoloA . The use of fibrin glue in the surgery of breast carcinoma. Il Giornale di Chirurgia1993;14:239-41. ">Gioffrè Florio 1993</a>; <a href="./references#CD009557-bbs2-0007" title="JohnsonL , CusickTE , HelmerSD , OslandJS . Influence of fibrin glue on seroma formation after breast surgery. American Journal of Surgery2005;189:319-23. ">Johnson 2005</a>; <a href="./references#CD009557-bbs2-0008" title="KoE , HanW , ChoJ , LeeJW , KangSY , JungSY , et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. Journal of Korean Medical Science2009;24:92-6. ">Ko 2009</a>; <a href="./references#CD009557-bbs2-0009" title="LangerS , GuentherJM , DiFronzoLA . Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?American Surgeon2003;69:77-81. ">Langer 2003</a>; <a href="./references#CD009557-bbs2-0010" title="MooreMM , NguyenDH , SpotnitzWD . Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. American Surgeon1997;63:97-102. ">Moore 1997</a>; <a href="./references#CD009557-bbs2-0011" title="MooreM , Burak WE Jr, NelsonE , KearneyT , SimmonsR , MayersL , et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. Journal of the American College of Surgeons2001;192:591-9. ">Moore 2001</a>; <a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>; <a href="./references#CD009557-bbs2-0013" title="RuggieroR , ProcacciniE , GiliS , CremoneC , ParmeggianiD , ConzoG , et al. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. Il Giornale di Chirurgia2009;30:306-10. ">Ruggiero 2009</a>; <a href="./references#CD009557-bbs2-0014" title="Segura-CastilloJL , Estrada-RiveraO , Castro-CervantesJM , Cortés-FloresAO , Velázquez-RamírezGA , González-OjedaA . Reduction of lymphatic drainage posterior to modified radical mastectomy with the application of fibrin glue. Cirugia y Circujanos2005;73(5):345-50. ">Segura‐Castillo 2005</a>; <a href="./references#CD009557-bbs2-0015" title="TasinatoR , GodinaM , GriggioL , Da DaltGF , ScuderiA , ReschiglianE . Prevention of axillary seromas in patients who underwent limphadenectomy for breast cancer. Acta Chirurgica Italica1993;49(1):479-84. ">Tasinato 1993</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>). </p> </section> <section id="CD009557-sec-0051"> <h4 class="title">Selective reporting</h4> <p>In judging the risk of bias for selective reporting, we were unable to assess the trial protocols and therefore assessed the studies based on the prespecified outcome measures reported in the methods section of the trial report. There were 16 studies with a low risk of bias due to adequate reporting of primary and secondary outcomes whereas two studies had a high risk of bias due to not optimally reporting secondary outcomes (<a href="./references#CD009557-bbs2-0006" title="JainPK , SowdiR , AndersonAD , MacFieJ . Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. The British Journal of Surgery2004;91:54-60. ">Jain 2004</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>). </p> </section> <section id="CD009557-sec-0052"> <h4 class="title">Other potential sources of bias</h4> <p>There have been published studies suggesting that industry‐sponsored trials may overestimate the treatment effect (<a href="./references#CD009557-bbs2-0022" title="BhandariM , BusseJW , JackowskiD , MontoriVM , SchünemannH , SpragueS . Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Canadian Medical Association Journal2004;170:477-80.">Bhandari 2004</a>; <a href="./references#CD009557-bbs2-0086" title="ThomasO , ThabaneL , DouketisJ , ChuR , WestfallAO , AllisonDB . Industry funding and the reporting quality of large long-term weight loss trials. International Journal of Obesity2008;32:1531-6.">Thomas 2008</a>). Six included trials did not report the ethics approval of the trial (<a href="./references#CD009557-bbs2-0003" title="El-NakeebA . Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study. The Breast Journal2009;15:671-2. ">El‐Nakeeb 2009</a>; <a href="./references#CD009557-bbs2-0005" title="Gioffrè FlorioMA , MezzasalmaF , ManganaroT , PakravananH , CogliandoloA . The use of fibrin glue in the surgery of breast carcinoma. Il Giornale di Chirurgia1993;14:239-41. ">Gioffrè Florio 1993</a>; <a href="./references#CD009557-bbs2-0004" title="GillyFN , FrançoisY , Sayag-BeaujardAC , GlehenO , BrachetA , VignalJ . Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. European Surgical Research1998;30:439-43. ">Gilly 1998</a>; <a href="./references#CD009557-bbs2-0013" title="RuggieroR , ProcacciniE , GiliS , CremoneC , ParmeggianiD , ConzoG , et al. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. Il Giornale di Chirurgia2009;30:306-10. ">Ruggiero 2009</a>; <a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>). In addition, five of these trials also failed to report any conflict of interest (<a href="./references#CD009557-bbs2-0003" title="El-NakeebA . Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study. The Breast Journal2009;15:671-2. ">El‐Nakeeb 2009</a>; <a href="./references#CD009557-bbs2-0004" title="GillyFN , FrançoisY , Sayag-BeaujardAC , GlehenO , BrachetA , VignalJ . Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. European Surgical Research1998;30:439-43. ">Gilly 1998</a>; <a href="./references#CD009557-bbs2-0013" title="RuggieroR , ProcacciniE , GiliS , CremoneC , ParmeggianiD , ConzoG , et al. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. Il Giornale di Chirurgia2009;30:306-10. ">Ruggiero 2009</a>; <a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>). The acknowledgement section of the published RCTs was incompletely reported. </p> </section> </section> <section id="CD009557-sec-0053"> <h3 class="title" id="CD009557-sec-0053">Effects of interventions</h3> <p>See: <a href="./full#CD009557-tbl-0001"><b>Summary of findings 1</b> Fibrin glue instillation under skin flaps compared to no‐fibrin for breast and axillary surgery</a> </p> <section id="CD009557-sec-0054"> <h4 class="title">All trials analysis</h4> <p>See: <a href="./full#CD009557-tbl-0001">summary of findings Table 1</a>. </p> <section id="CD009557-sec-0055"> <h5 class="title">Incidence of postoperative wound site seroma</h5> <p>All trials contributed to the combined calculation of this variable (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>; <a href="./references#CD009557-bbs2-0002" title="DinsmoreRC , HarrisJA , GustafsonRJ . Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. American Surgeon2000;66:982-5. ">Dinsmore 2000</a>; <a href="./references#CD009557-bbs2-0003" title="El-NakeebA . Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study. The Breast Journal2009;15:671-2. ">El‐Nakeeb 2009</a>; <a href="./references#CD009557-bbs2-0004" title="GillyFN , FrançoisY , Sayag-BeaujardAC , GlehenO , BrachetA , VignalJ . Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. European Surgical Research1998;30:439-43. ">Gilly 1998</a>; <a href="./references#CD009557-bbs2-0005" title="Gioffrè FlorioMA , MezzasalmaF , ManganaroT , PakravananH , CogliandoloA . The use of fibrin glue in the surgery of breast carcinoma. Il Giornale di Chirurgia1993;14:239-41. ">Gioffrè Florio 1993</a>; <a href="./references#CD009557-bbs2-0006" title="JainPK , SowdiR , AndersonAD , MacFieJ . Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. The British Journal of Surgery2004;91:54-60. ">Jain 2004</a>; <a href="./references#CD009557-bbs2-0007" title="JohnsonL , CusickTE , HelmerSD , OslandJS . Influence of fibrin glue on seroma formation after breast surgery. American Journal of Surgery2005;189:319-23. ">Johnson 2005</a>; <a href="./references#CD009557-bbs2-0008" title="KoE , HanW , ChoJ , LeeJW , KangSY , JungSY , et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. Journal of Korean Medical Science2009;24:92-6. ">Ko 2009</a>; <a href="./references#CD009557-bbs2-0009" title="LangerS , GuentherJM , DiFronzoLA . Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?American Surgeon2003;69:77-81. ">Langer 2003</a>; <a href="./references#CD009557-bbs2-0010" title="MooreMM , NguyenDH , SpotnitzWD . Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. American Surgeon1997;63:97-102. ">Moore 1997</a>; <a href="./references#CD009557-bbs2-0011" title="MooreM , Burak WE Jr, NelsonE , KearneyT , SimmonsR , MayersL , et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. Journal of the American College of Surgeons2001;192:591-9. ">Moore 2001</a>; <a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>; <a href="./references#CD009557-bbs2-0013" title="RuggieroR , ProcacciniE , GiliS , CremoneC , ParmeggianiD , ConzoG , et al. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. Il Giornale di Chirurgia2009;30:306-10. ">Ruggiero 2009</a>; <a href="./references#CD009557-bbs2-0014" title="Segura-CastilloJL , Estrada-RiveraO , Castro-CervantesJM , Cortés-FloresAO , Velázquez-RamírezGA , González-OjedaA . Reduction of lymphatic drainage posterior to modified radical mastectomy with the application of fibrin glue. Cirugia y Circujanos2005;73(5):345-50. ">Segura‐Castillo 2005</a>; <a href="./references#CD009557-bbs2-0015" title="TasinatoR , GodinaM , GriggioL , Da DaltGF , ScuderiA , ReschiglianE . Prevention of axillary seromas in patients who underwent limphadenectomy for breast cancer. Acta Chirurgica Italica1993;49(1):479-84. ">Tasinato 1993</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>).There was no significant heterogeneity (I<sup>2</sup> = 15%) among studies. Therefore, in the fixed‐effect model, FG was statistically ineffective in reducing the incidence of postoperative seroma in people undergoing breast and axillary surgery (RR 1.02; 95% CI 0.90 to 1.16, P value = 0.73; <a href="./references#CD009557-fig-0006" title="">Analysis 1.1</a>, refer to <a href="#CD009557-fig-0002">Figure 2</a>). </p> <div class="figure" id="CD009557-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 All trials analysis, outcome: 1.1 Incidence of postoperative seroma." data-id="CD009557-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 All trials analysis, outcome: 1.1 Incidence of postoperative seroma. </p> </div> </div> </div> </section> <section id="CD009557-sec-0056"> <h5 class="title">Mean volume of seroma</h5> <p>There was significant heterogeneity (I<sup>2</sup> = 94%) among 10 studies contributing to the combined calculation of this variable (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>; <a href="./references#CD009557-bbs2-0003" title="El-NakeebA . Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study. The Breast Journal2009;15:671-2. ">El‐Nakeeb 2009</a>; <a href="./references#CD009557-bbs2-0005" title="Gioffrè FlorioMA , MezzasalmaF , ManganaroT , PakravananH , CogliandoloA . The use of fibrin glue in the surgery of breast carcinoma. Il Giornale di Chirurgia1993;14:239-41. ">Gioffrè Florio 1993</a>; <a href="./references#CD009557-bbs2-0006" title="JainPK , SowdiR , AndersonAD , MacFieJ . Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. The British Journal of Surgery2004;91:54-60. ">Jain 2004</a>; <a href="./references#CD009557-bbs2-0007" title="JohnsonL , CusickTE , HelmerSD , OslandJS . Influence of fibrin glue on seroma formation after breast surgery. American Journal of Surgery2005;189:319-23. ">Johnson 2005</a>; <a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>; <a href="./references#CD009557-bbs2-0015" title="TasinatoR , GodinaM , GriggioL , Da DaltGF , ScuderiA , ReschiglianE . Prevention of axillary seromas in patients who underwent limphadenectomy for breast cancer. Acta Chirurgica Italica1993;49(1):479-84. ">Tasinato 1993</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>). In the random‐effects model, the mean volume of the seroma remained unchanged with and without application of FG under skin flaps following axillary and breast surgery (SMD ‐0.25; 95% CI ‐0.92 to 0.42, P value = 0.46; <a href="./references#CD009557-fig-0007" title="">Analysis 1.2</a>). </p> </section> <section id="CD009557-sec-0057"> <h5 class="title">Total volume of drained fluid</h5> <p>There was significant heterogeneity (I<sup>2</sup> = 91%) among 13 studies (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>; <a href="./references#CD009557-bbs2-0002" title="DinsmoreRC , HarrisJA , GustafsonRJ . Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. American Surgeon2000;66:982-5. ">Dinsmore 2000</a>; <a href="./references#CD009557-bbs2-0003" title="El-NakeebA . Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study. The Breast Journal2009;15:671-2. ">El‐Nakeeb 2009</a>; <a href="./references#CD009557-bbs2-0004" title="GillyFN , FrançoisY , Sayag-BeaujardAC , GlehenO , BrachetA , VignalJ . Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. European Surgical Research1998;30:439-43. ">Gilly 1998</a>; <a href="./references#CD009557-bbs2-0008" title="KoE , HanW , ChoJ , LeeJW , KangSY , JungSY , et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. Journal of Korean Medical Science2009;24:92-6. ">Ko 2009</a>; <a href="./references#CD009557-bbs2-0009" title="LangerS , GuentherJM , DiFronzoLA . Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?American Surgeon2003;69:77-81. ">Langer 2003</a>; <a href="./references#CD009557-bbs2-0010" title="MooreMM , NguyenDH , SpotnitzWD . Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. American Surgeon1997;63:97-102. ">Moore 1997</a>; <a href="./references#CD009557-bbs2-0011" title="MooreM , Burak WE Jr, NelsonE , KearneyT , SimmonsR , MayersL , et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. Journal of the American College of Surgeons2001;192:591-9. ">Moore 2001</a>; <a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>; <a href="./references#CD009557-bbs2-0013" title="RuggieroR , ProcacciniE , GiliS , CremoneC , ParmeggianiD , ConzoG , et al. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. Il Giornale di Chirurgia2009;30:306-10. ">Ruggiero 2009</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>) contributing to the combined calculation of this variable. In the random‐effects model, the total volume of drained seroma fluid reduced significantly with the application of FG under skin flaps following axillary and breast surgery (SMD ‐0.75; 95% CI ‐1.24 to ‐0.26, P value = 0.003; <a href="./references#CD009557-fig-0008" title="">Analysis 1.3</a>). </p> </section> <section id="CD009557-sec-0058"> <h5 class="title">Number of days for persistent seroma drainage</h5> <p>There was significant heterogeneity (I<sup>2</sup> = 83%) among 13 studies contributing to the combined calculation of this variable (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>; <a href="./references#CD009557-bbs2-0002" title="DinsmoreRC , HarrisJA , GustafsonRJ . Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. American Surgeon2000;66:982-5. ">Dinsmore 2000</a>; <a href="./references#CD009557-bbs2-0003" title="El-NakeebA . Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study. The Breast Journal2009;15:671-2. ">El‐Nakeeb 2009</a>; <a href="./references#CD009557-bbs2-0008" title="KoE , HanW , ChoJ , LeeJW , KangSY , JungSY , et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. Journal of Korean Medical Science2009;24:92-6. ">Ko 2009</a>; <a href="./references#CD009557-bbs2-0009" title="LangerS , GuentherJM , DiFronzoLA . Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?American Surgeon2003;69:77-81. ">Langer 2003</a>; <a href="./references#CD009557-bbs2-0010" title="MooreMM , NguyenDH , SpotnitzWD . Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. American Surgeon1997;63:97-102. ">Moore 1997</a>; <a href="./references#CD009557-bbs2-0011" title="MooreM , Burak WE Jr, NelsonE , KearneyT , SimmonsR , MayersL , et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. Journal of the American College of Surgeons2001;192:591-9. ">Moore 2001</a>; <a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>; <a href="./references#CD009557-bbs2-0014" title="Segura-CastilloJL , Estrada-RiveraO , Castro-CervantesJM , Cortés-FloresAO , Velázquez-RamírezGA , González-OjedaA . Reduction of lymphatic drainage posterior to modified radical mastectomy with the application of fibrin glue. Cirugia y Circujanos2005;73(5):345-50. ">Segura‐Castillo 2005</a>; <a href="./references#CD009557-bbs2-0015" title="TasinatoR , GodinaM , GriggioL , Da DaltGF , ScuderiA , ReschiglianE . Prevention of axillary seromas in patients who underwent limphadenectomy for breast cancer. Acta Chirurgica Italica1993;49(1):479-84. ">Tasinato 1993</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>). In the random‐effects model, the total duration of persistent seroma drainage reduced significantly with the application of FG under skin flaps following axillary and breast surgery (SMD ‐0.59; 95% CI ‐0.95 to ‐0.23, P value &lt; 0.001; <a href="./references#CD009557-fig-0009" title="">Analysis 1.4</a>). </p> </section> <section id="CD009557-sec-0059"> <h5 class="title">Surgical site infection</h5> <p>Thirteen trials contributed to the combined calculation of the risk of surgical site infection in participants with and without the use of FG (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>; <a href="./references#CD009557-bbs2-0002" title="DinsmoreRC , HarrisJA , GustafsonRJ . Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. American Surgeon2000;66:982-5. ">Dinsmore 2000</a>; <a href="./references#CD009557-bbs2-0006" title="JainPK , SowdiR , AndersonAD , MacFieJ . Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. The British Journal of Surgery2004;91:54-60. ">Jain 2004</a>; <a href="./references#CD009557-bbs2-0007" title="JohnsonL , CusickTE , HelmerSD , OslandJS . Influence of fibrin glue on seroma formation after breast surgery. American Journal of Surgery2005;189:319-23. ">Johnson 2005</a> ; <a href="./references#CD009557-bbs2-0008" title="KoE , HanW , ChoJ , LeeJW , KangSY , JungSY , et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. Journal of Korean Medical Science2009;24:92-6. ">Ko 2009</a>; <a href="./references#CD009557-bbs2-0009" title="LangerS , GuentherJM , DiFronzoLA . Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?American Surgeon2003;69:77-81. ">Langer 2003</a>; <a href="./references#CD009557-bbs2-0011" title="MooreM , Burak WE Jr, NelsonE , KearneyT , SimmonsR , MayersL , et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. Journal of the American College of Surgeons2001;192:591-9. ">Moore 2001</a>; <a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>; <a href="./references#CD009557-bbs2-0013" title="RuggieroR , ProcacciniE , GiliS , CremoneC , ParmeggianiD , ConzoG , et al. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. Il Giornale di Chirurgia2009;30:306-10. ">Ruggiero 2009</a>; <a href="./references#CD009557-bbs2-0014" title="Segura-CastilloJL , Estrada-RiveraO , Castro-CervantesJM , Cortés-FloresAO , Velázquez-RamírezGA , González-OjedaA . Reduction of lymphatic drainage posterior to modified radical mastectomy with the application of fibrin glue. Cirugia y Circujanos2005;73(5):345-50. ">Segura‐Castillo 2005</a>; <a href="./references#CD009557-bbs2-0015" title="TasinatoR , GodinaM , GriggioL , Da DaltGF , ScuderiA , ReschiglianE . Prevention of axillary seromas in patients who underwent limphadenectomy for breast cancer. Acta Chirurgica Italica1993;49(1):479-84. ">Tasinato 1993</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>). There was no heterogeneity (I<sup>2</sup> = 0%) among included studies. Therefore, in the fixed‐effect model, the use of FG was not associated with an increased incidence of surgical site infection in people undergoing breast and axillary surgery for cancer (RR 1.05; 95% CI 0.63 to 1.77, P value = 0.84; <a href="./references#CD009557-fig-0010" title="">Analysis 1.5</a>, refer to <a href="#CD009557-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD009557-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 All trials analysis, outcome: 1.5 Surgical site infection." data-id="CD009557-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 All trials analysis, outcome: 1.5 Surgical site infection.</p> </div> </div> </div> </section> <section id="CD009557-sec-0060"> <h5 class="title">Postoperative complications</h5> <p>Eleven trials contributed to the combined calculation of the risk of surgical site infection in participants with and without the use of FG (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>; <a href="./references#CD009557-bbs2-0004" title="GillyFN , FrançoisY , Sayag-BeaujardAC , GlehenO , BrachetA , VignalJ . Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. European Surgical Research1998;30:439-43. ">Gilly 1998</a>; <a href="./references#CD009557-bbs2-0006" title="JainPK , SowdiR , AndersonAD , MacFieJ . Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. The British Journal of Surgery2004;91:54-60. ">Jain 2004</a>; <a href="./references#CD009557-bbs2-0007" title="JohnsonL , CusickTE , HelmerSD , OslandJS . Influence of fibrin glue on seroma formation after breast surgery. American Journal of Surgery2005;189:319-23. ">Johnson 2005</a>; <a href="./references#CD009557-bbs2-0008" title="KoE , HanW , ChoJ , LeeJW , KangSY , JungSY , et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. Journal of Korean Medical Science2009;24:92-6. ">Ko 2009</a>; <a href="./references#CD009557-bbs2-0011" title="MooreM , Burak WE Jr, NelsonE , KearneyT , SimmonsR , MayersL , et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. Journal of the American College of Surgeons2001;192:591-9. ">Moore 2001</a>; <a href="./references#CD009557-bbs2-0013" title="RuggieroR , ProcacciniE , GiliS , CremoneC , ParmeggianiD , ConzoG , et al. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. Il Giornale di Chirurgia2009;30:306-10. ">Ruggiero 2009</a>; <a href="./references#CD009557-bbs2-0014" title="Segura-CastilloJL , Estrada-RiveraO , Castro-CervantesJM , Cortés-FloresAO , Velázquez-RamírezGA , González-OjedaA . Reduction of lymphatic drainage posterior to modified radical mastectomy with the application of fibrin glue. Cirugia y Circujanos2005;73(5):345-50. ">Segura‐Castillo 2005</a>; <a href="./references#CD009557-bbs2-0015" title="TasinatoR , GodinaM , GriggioL , Da DaltGF , ScuderiA , ReschiglianE . Prevention of axillary seromas in patients who underwent limphadenectomy for breast cancer. Acta Chirurgica Italica1993;49(1):479-84. ">Tasinato 1993</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>). There was no heterogeneity (I<sup>2</sup> = 0%) among included studies. Therefore, in the fixed‐effect model, the use of FG was not associated with an increased incidence of postoperative complications in people undergoing breast and axillary surgery for cancer (RR 1.13; 95% CI 0.63 to 2.04, P value = 0.68; <a href="./references#CD009557-fig-0011" title="">Analysis 1.6</a>, refer to <a href="#CD009557-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD009557-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 All trials analysis, outcome: 1.6 Postoperative complications." data-id="CD009557-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 All trials analysis, outcome: 1.6 Postoperative complications.</p> </div> </div> </div> </section> <section id="CD009557-sec-0061"> <h5 class="title">Length of hospital stay</h5> <p>There was significant heterogeneity (I<sup>2</sup> = 86%) among six studies contributing to the combined calculation of this variable (<a href="./references#CD009557-bbs2-0004" title="GillyFN , FrançoisY , Sayag-BeaujardAC , GlehenO , BrachetA , VignalJ . Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. European Surgical Research1998;30:439-43. ">Gilly 1998</a>; <a href="./references#CD009557-bbs2-0006" title="JainPK , SowdiR , AndersonAD , MacFieJ . Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. The British Journal of Surgery2004;91:54-60. ">Jain 2004</a>; <a href="./references#CD009557-bbs2-0010" title="MooreMM , NguyenDH , SpotnitzWD . Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. American Surgeon1997;63:97-102. ">Moore 1997</a>; <a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>). In the random‐effects model, the length of hospital stay between two groups was statistically the same (SMD ‐0.20; 95% CI ‐0.78 to 0.39, P value = 0.51; <a href="./references#CD009557-fig-0012" title="">Analysis 1.7</a>). </p> </section> </section> <section id="CD009557-sec-0062"> <h4 class="title">Subgroup analysis of trials on mastectomy</h4> <p>Ten RCTs encompassing 629 participants undergoing breast surgery for breast cancer were retrieved from the electronic databases (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>; <a href="./references#CD009557-bbs2-0002" title="DinsmoreRC , HarrisJA , GustafsonRJ . Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. American Surgeon2000;66:982-5. ">Dinsmore 2000</a>; <a href="./references#CD009557-bbs2-0003" title="El-NakeebA . Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study. The Breast Journal2009;15:671-2. ">El‐Nakeeb 2009</a>; <a href="./references#CD009557-bbs2-0010" title="MooreMM , NguyenDH , SpotnitzWD . Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. American Surgeon1997;63:97-102. ">Moore 1997</a>; <a href="./references#CD009557-bbs2-0011" title="MooreM , Burak WE Jr, NelsonE , KearneyT , SimmonsR , MayersL , et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. Journal of the American College of Surgeons2001;192:591-9. ">Moore 2001</a>; <a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>; <a href="./references#CD009557-bbs2-0015" title="TasinatoR , GodinaM , GriggioL , Da DaltGF , ScuderiA , ReschiglianE . Prevention of axillary seromas in patients who underwent limphadenectomy for breast cancer. Acta Chirurgica Italica1993;49(1):479-84. ">Tasinato 1993</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>). There were 335 people in the FG group and 294 people in the NFG group. </p> <section id="CD009557-sec-0063"> <h5 class="title">Incidence of postoperative wound site seroma</h5> <p>All 10 trials contributed to the combined calculation of this variable (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>; <a href="./references#CD009557-bbs2-0002" title="DinsmoreRC , HarrisJA , GustafsonRJ . Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. American Surgeon2000;66:982-5. ">Dinsmore 2000</a>; <a href="./references#CD009557-bbs2-0003" title="El-NakeebA . Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study. The Breast Journal2009;15:671-2. ">El‐Nakeeb 2009</a>; <a href="./references#CD009557-bbs2-0010" title="MooreMM , NguyenDH , SpotnitzWD . Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. American Surgeon1997;63:97-102. ">Moore 1997</a>; <a href="./references#CD009557-bbs2-0011" title="MooreM , Burak WE Jr, NelsonE , KearneyT , SimmonsR , MayersL , et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. Journal of the American College of Surgeons2001;192:591-9. ">Moore 2001</a>; <a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>; <a href="./references#CD009557-bbs2-0015" title="TasinatoR , GodinaM , GriggioL , Da DaltGF , ScuderiA , ReschiglianE . Prevention of axillary seromas in patients who underwent limphadenectomy for breast cancer. Acta Chirurgica Italica1993;49(1):479-84. ">Tasinato 1993</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>). There was no significant heterogeneity (I<sup>2</sup> = 10%) among studies. Therefore, in the fixed‐effect model, FG was statistically ineffective in reducing the incidence of postoperative seroma in people undergoing breast and axillary surgery (RR 1.02; 95% CI 0.90 to 1.15, P value = 0.80; <a href="./references#CD009557-fig-0013" title="">Analysis 2.1</a>). </p> </section> <section id="CD009557-sec-0064"> <h5 class="title">Mean volume of seroma</h5> <p>There was significant heterogeneity (I<sup>2</sup> = 72%) among six studies (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>; <a href="./references#CD009557-bbs2-0003" title="El-NakeebA . Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study. The Breast Journal2009;15:671-2. ">El‐Nakeeb 2009</a>; <a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>) contributing to the combined calculation of this variable. In the random‐effects model, the mean volume of the seroma remained unchanged with and without the application of FG under skin flaps following axillary and breast surgery (SMD ‐0.24; 95% CI ‐0.63 to 0.15, P value = 0.23; <a href="./references#CD009557-fig-0014" title="">Analysis 2.2</a>). </p> </section> <section id="CD009557-sec-0065"> <h5 class="title">Total volume of drained fluid</h5> <p>There was significant heterogeneity (I<sup>2</sup> = 93%) among 10 studies contributing to the combined calculation of this variable (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>; <a href="./references#CD009557-bbs2-0002" title="DinsmoreRC , HarrisJA , GustafsonRJ . Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. American Surgeon2000;66:982-5. ">Dinsmore 2000</a>; <a href="./references#CD009557-bbs2-0003" title="El-NakeebA . Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study. The Breast Journal2009;15:671-2. ">El‐Nakeeb 2009</a>; <a href="./references#CD009557-bbs2-0010" title="MooreMM , NguyenDH , SpotnitzWD . Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. American Surgeon1997;63:97-102. ">Moore 1997</a>; <a href="./references#CD009557-bbs2-0011" title="MooreM , Burak WE Jr, NelsonE , KearneyT , SimmonsR , MayersL , et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. Journal of the American College of Surgeons2001;192:591-9. ">Moore 2001</a>; <a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>; <a href="./references#CD009557-bbs2-0013" title="RuggieroR , ProcacciniE , GiliS , CremoneC , ParmeggianiD , ConzoG , et al. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. Il Giornale di Chirurgia2009;30:306-10. ">Ruggiero 2009</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>). In the random‐effects model, the total volume of drained seroma fluid reduced significantly with the application of FG under skin flaps following axillary and breast surgery (SMD ‐0.83; 95% CI ‐1.50 to ‐0.17, P value &lt; 0.01; <a href="./references#CD009557-fig-0015" title="">Analysis 2.3</a>). </p> </section> <section id="CD009557-sec-0066"> <h5 class="title">Number of days for persistent seroma drainage</h5> <p>There was significant heterogeneity (I<sup>2</sup> = 72%) among nine studies contributing to the combined calculation of this variable (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>; <a href="./references#CD009557-bbs2-0002" title="DinsmoreRC , HarrisJA , GustafsonRJ . Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. American Surgeon2000;66:982-5. ">Dinsmore 2000</a>; <a href="./references#CD009557-bbs2-0003" title="El-NakeebA . Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study. The Breast Journal2009;15:671-2. ">El‐Nakeeb 2009</a>; <a href="./references#CD009557-bbs2-0010" title="MooreMM , NguyenDH , SpotnitzWD . Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. American Surgeon1997;63:97-102. ">Moore 1997</a>; <a href="./references#CD009557-bbs2-0011" title="MooreM , Burak WE Jr, NelsonE , KearneyT , SimmonsR , MayersL , et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. Journal of the American College of Surgeons2001;192:591-9. ">Moore 2001</a>; <a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>). In the random‐effects model, the total duration of persistent seroma drainage reduced significantly with the application of FG under skin flaps following axillary and breast surgery (SMD ‐0.36; 95% CI ‐0.71 to ‐0.01; P value &lt; 0.04; <a href="./references#CD009557-fig-0016" title="">Analysis 2.4</a>). </p> </section> <section id="CD009557-sec-0067"> <h5 class="title">Surgical site infection</h5> <p>Eight trials contributed to the combined calculation of the risk of surgical site infection in people with and without the use of FG (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>; <a href="./references#CD009557-bbs2-0002" title="DinsmoreRC , HarrisJA , GustafsonRJ . Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. American Surgeon2000;66:982-5. ">Dinsmore 2000</a>; <a href="./references#CD009557-bbs2-0010" title="MooreMM , NguyenDH , SpotnitzWD . Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. American Surgeon1997;63:97-102. ">Moore 1997</a>; <a href="./references#CD009557-bbs2-0011" title="MooreM , Burak WE Jr, NelsonE , KearneyT , SimmonsR , MayersL , et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. Journal of the American College of Surgeons2001;192:591-9. ">Moore 2001</a>; <a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>; <a href="./references#CD009557-bbs2-0013" title="RuggieroR , ProcacciniE , GiliS , CremoneC , ParmeggianiD , ConzoG , et al. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. Il Giornale di Chirurgia2009;30:306-10. ">Ruggiero 2009</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>). There was no heterogeneity (I<sup>2</sup> = 0%) among included studies. Therefore, in the fixed‐effect model, the use of FG was not associated with an increased incidence of surgical site infection in people undergoing breast and axillary surgery for cancer (RR 1.13; 95% CI 0.60 to 2.10, P value = 0.71; <a href="./references#CD009557-fig-0017" title="">Analysis 2.5</a>). </p> </section> <section id="CD009557-sec-0068"> <h5 class="title">Postoperative complications</h5> <p>Five trials contributed to the combined calculation of the risk of surgical site infection in people with and without the use of FG (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>; <a href="./references#CD009557-bbs2-0011" title="MooreM , Burak WE Jr, NelsonE , KearneyT , SimmonsR , MayersL , et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. Journal of the American College of Surgeons2001;192:591-9. ">Moore 2001</a>; <a href="./references#CD009557-bbs2-0013" title="RuggieroR , ProcacciniE , GiliS , CremoneC , ParmeggianiD , ConzoG , et al. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. Il Giornale di Chirurgia2009;30:306-10. ">Ruggiero 2009</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>). There was no heterogeneity (I<sup>2</sup> = 14%) among included studies. Therefore, in the fixed‐effect model, the use of FG was not associated with an increased incidence of postoperative complications in people undergoing breast and axillary surgery for cancer (RR 1.35; 95% CI 0.59 to 3.12, P value = 0.48; <a href="./references#CD009557-fig-0018" title="">Analysis 2.6</a>). </p> </section> <section id="CD009557-sec-0069"> <h5 class="title">Length of hospital stay</h5> <p>There was no heterogeneity (I<sup>2</sup> = 0%) among four studies contributing to the combined calculation of this variable (<a href="./references#CD009557-bbs2-0010" title="MooreMM , NguyenDH , SpotnitzWD . Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. American Surgeon1997;63:97-102. ">Moore 1997</a>; <a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>). In the random‐effects model, the length of hospital stay between two groups was statistically the same (SMD 0.28; 95% CI ‐0.02 to 0.59, P value = 0.07; <a href="./references#CD009557-fig-0019" title="">Analysis 2.7</a>). </p> </section> </section> <section id="CD009557-sec-0070"> <h4 class="title">Subgroup analysis of trials on mastectomy plus axillary surgery</h4> <p>Seven RCTs encompassing 496 participants undergoing breast plus axillary surgery for breast cancer were retrieved from the electronic databases (<a href="./references#CD009557-bbs2-0004" title="GillyFN , FrançoisY , Sayag-BeaujardAC , GlehenO , BrachetA , VignalJ . Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. European Surgical Research1998;30:439-43. ">Gilly 1998</a>; <a href="./references#CD009557-bbs2-0005" title="Gioffrè FlorioMA , MezzasalmaF , ManganaroT , PakravananH , CogliandoloA . The use of fibrin glue in the surgery of breast carcinoma. Il Giornale di Chirurgia1993;14:239-41. ">Gioffrè Florio 1993</a>; <a href="./references#CD009557-bbs2-0006" title="JainPK , SowdiR , AndersonAD , MacFieJ . Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. The British Journal of Surgery2004;91:54-60. ">Jain 2004</a>; <a href="./references#CD009557-bbs2-0007" title="JohnsonL , CusickTE , HelmerSD , OslandJS . Influence of fibrin glue on seroma formation after breast surgery. American Journal of Surgery2005;189:319-23. ">Johnson 2005</a>; <a href="./references#CD009557-bbs2-0008" title="KoE , HanW , ChoJ , LeeJW , KangSY , JungSY , et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. Journal of Korean Medical Science2009;24:92-6. ">Ko 2009</a>; <a href="./references#CD009557-bbs2-0009" title="LangerS , GuentherJM , DiFronzoLA . Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?American Surgeon2003;69:77-81. ">Langer 2003</a>; <a href="./references#CD009557-bbs2-0014" title="Segura-CastilloJL , Estrada-RiveraO , Castro-CervantesJM , Cortés-FloresAO , Velázquez-RamírezGA , González-OjedaA . Reduction of lymphatic drainage posterior to modified radical mastectomy with the application of fibrin glue. Cirugia y Circujanos2005;73(5):345-50. ">Segura‐Castillo 2005</a>). There were 224 people in the FG group and 272 people in the NFG group. </p> <section id="CD009557-sec-0071"> <h5 class="title">Incidence of postoperative wound site seroma</h5> <p>Seven trials contributed to the combined calculation of this variable (<a href="./references#CD009557-bbs2-0004" title="GillyFN , FrançoisY , Sayag-BeaujardAC , GlehenO , BrachetA , VignalJ . Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. European Surgical Research1998;30:439-43. ">Gilly 1998</a>; <a href="./references#CD009557-bbs2-0005" title="Gioffrè FlorioMA , MezzasalmaF , ManganaroT , PakravananH , CogliandoloA . The use of fibrin glue in the surgery of breast carcinoma. Il Giornale di Chirurgia1993;14:239-41. ">Gioffrè Florio 1993</a>; <a href="./references#CD009557-bbs2-0006" title="JainPK , SowdiR , AndersonAD , MacFieJ . Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. The British Journal of Surgery2004;91:54-60. ">Jain 2004</a>; <a href="./references#CD009557-bbs2-0007" title="JohnsonL , CusickTE , HelmerSD , OslandJS . Influence of fibrin glue on seroma formation after breast surgery. American Journal of Surgery2005;189:319-23. ">Johnson 2005</a>; <a href="./references#CD009557-bbs2-0008" title="KoE , HanW , ChoJ , LeeJW , KangSY , JungSY , et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. Journal of Korean Medical Science2009;24:92-6. ">Ko 2009</a>; <a href="./references#CD009557-bbs2-0009" title="LangerS , GuentherJM , DiFronzoLA . Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?American Surgeon2003;69:77-81. ">Langer 2003</a>; <a href="./references#CD009557-bbs2-0014" title="Segura-CastilloJL , Estrada-RiveraO , Castro-CervantesJM , Cortés-FloresAO , Velázquez-RamírezGA , González-OjedaA . Reduction of lymphatic drainage posterior to modified radical mastectomy with the application of fibrin glue. Cirugia y Circujanos2005;73(5):345-50. ">Segura‐Castillo 2005</a>). There was no significant heterogeneity (I<sup>2</sup> = 16%) among studies. Therefore, in the fixed‐effect model, FG was statistically ineffective in reducing the incidence of postoperative seroma in participants undergoing breast and axillary surgery (RR 1.04; 95% CI 0.72 to 1.51; P value = 0.82; <a href="./references#CD009557-fig-0020" title="">Analysis 3.1</a>). </p> </section> <section id="CD009557-sec-0072"> <h5 class="title">Mean volume of seroma</h5> <p>There was significant heterogeneity (I<sup>2</sup> = 96%) among three studies contributing to the combined calculation of this variable (<a href="./references#CD009557-bbs2-0005" title="Gioffrè FlorioMA , MezzasalmaF , ManganaroT , PakravananH , CogliandoloA . The use of fibrin glue in the surgery of breast carcinoma. Il Giornale di Chirurgia1993;14:239-41. ">Gioffrè Florio 1993</a>; <a href="./references#CD009557-bbs2-0006" title="JainPK , SowdiR , AndersonAD , MacFieJ . Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. The British Journal of Surgery2004;91:54-60. ">Jain 2004</a>; <a href="./references#CD009557-bbs2-0007" title="JohnsonL , CusickTE , HelmerSD , OslandJS . Influence of fibrin glue on seroma formation after breast surgery. American Journal of Surgery2005;189:319-23. ">Johnson 2005</a>). In the random‐effects model, the mean volume of the seroma remained unchanged with and without the application of FG under skin flaps following axillary and breast surgery (SMD ‐1.06; 95% CI ‐3.23 to 1.11, P value = 0.34; <a href="./references#CD009557-fig-0021" title="">Analysis 3.2</a>). </p> </section> <section id="CD009557-sec-0073"> <h5 class="title">Total volume of drained fluid</h5> <p>There was significant heterogeneity (I<sup>2</sup> = 76%) among three studies contributing to the combined calculation of this variable (<a href="./references#CD009557-bbs2-0004" title="GillyFN , FrançoisY , Sayag-BeaujardAC , GlehenO , BrachetA , VignalJ . Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. European Surgical Research1998;30:439-43. ">Gilly 1998</a>; <a href="./references#CD009557-bbs2-0008" title="KoE , HanW , ChoJ , LeeJW , KangSY , JungSY , et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. Journal of Korean Medical Science2009;24:92-6. ">Ko 2009</a>; <a href="./references#CD009557-bbs2-0009" title="LangerS , GuentherJM , DiFronzoLA . Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?American Surgeon2003;69:77-81. ">Langer 2003</a>). In the random‐effects model, the total volume of drained seroma fluid reduced significantly with the application of FG under skin flaps following axillary and breast surgery (SMD ‐0.54; 95% CI ‐1.06 to ‐0.02, P value &lt; 0.04; <a href="./references#CD009557-fig-0022" title="">Analysis 3.3</a>). </p> </section> <section id="CD009557-sec-0074"> <h5 class="title">Number of days for persistent seroma drainage</h5> <p>There was significant heterogeneity (I<sup>2</sup> = 86%) among three studies contributing to the combined calculation of this variable (<a href="./references#CD009557-bbs2-0008" title="KoE , HanW , ChoJ , LeeJW , KangSY , JungSY , et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. Journal of Korean Medical Science2009;24:92-6. ">Ko 2009</a>; <a href="./references#CD009557-bbs2-0009" title="LangerS , GuentherJM , DiFronzoLA . Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?American Surgeon2003;69:77-81. ">Langer 2003</a>; <a href="./references#CD009557-bbs2-0014" title="Segura-CastilloJL , Estrada-RiveraO , Castro-CervantesJM , Cortés-FloresAO , Velázquez-RamírezGA , González-OjedaA . Reduction of lymphatic drainage posterior to modified radical mastectomy with the application of fibrin glue. Cirugia y Circujanos2005;73(5):345-50. ">Segura‐Castillo 2005</a>). In the random‐effects model, the total duration of persistent seroma drainage reduced significantly with the application of FG under skin flaps following axillary and breast surgery (SMD ‐0.68; 95% CI ‐0.98 to ‐0.39, P value &lt; 0.001; <a href="./references#CD009557-fig-0023" title="">Analysis 3.4</a>). </p> </section> <section id="CD009557-sec-0075"> <h5 class="title">Surgical site infection</h5> <p>Five trials contributed to the combined calculation of the risk of surgical site infection in participants with and without the use of FG (<a href="./references#CD009557-bbs2-0006" title="JainPK , SowdiR , AndersonAD , MacFieJ . Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. The British Journal of Surgery2004;91:54-60. ">Jain 2004</a>; <a href="./references#CD009557-bbs2-0007" title="JohnsonL , CusickTE , HelmerSD , OslandJS . Influence of fibrin glue on seroma formation after breast surgery. American Journal of Surgery2005;189:319-23. ">Johnson 2005</a>; <a href="./references#CD009557-bbs2-0008" title="KoE , HanW , ChoJ , LeeJW , KangSY , JungSY , et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. Journal of Korean Medical Science2009;24:92-6. ">Ko 2009</a>; <a href="./references#CD009557-bbs2-0009" title="LangerS , GuentherJM , DiFronzoLA . Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?American Surgeon2003;69:77-81. ">Langer 2003</a>; <a href="./references#CD009557-bbs2-0014" title="Segura-CastilloJL , Estrada-RiveraO , Castro-CervantesJM , Cortés-FloresAO , Velázquez-RamírezGA , González-OjedaA . Reduction of lymphatic drainage posterior to modified radical mastectomy with the application of fibrin glue. Cirugia y Circujanos2005;73(5):345-50. ">Segura‐Castillo 2005</a>). There was no heterogeneity (I<sup>2</sup> = 0%) among included studies. Therefore, in the fixed‐effect model, the use of FG was not associated with an increased incidence of surgical site infection in people undergoing breast and axillary surgery for cancer (RR 1.18; 95% CI 0.44 to 3.16, P value = 0.74; <a href="./references#CD009557-fig-0024" title="">Analysis 3.5</a>). </p> </section> <section id="CD009557-sec-0076"> <h5 class="title">Postoperative complications</h5> <p>Five trials contributed to the combined calculation of the risk of surgical site infection in participants with and without the use of FG (<a href="./references#CD009557-bbs2-0004" title="GillyFN , FrançoisY , Sayag-BeaujardAC , GlehenO , BrachetA , VignalJ . Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. European Surgical Research1998;30:439-43. ">Gilly 1998</a>; <a href="./references#CD009557-bbs2-0006" title="JainPK , SowdiR , AndersonAD , MacFieJ . Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. The British Journal of Surgery2004;91:54-60. ">Jain 2004</a>; <a href="./references#CD009557-bbs2-0007" title="JohnsonL , CusickTE , HelmerSD , OslandJS . Influence of fibrin glue on seroma formation after breast surgery. American Journal of Surgery2005;189:319-23. ">Johnson 2005</a> ; <a href="./references#CD009557-bbs2-0008" title="KoE , HanW , ChoJ , LeeJW , KangSY , JungSY , et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. Journal of Korean Medical Science2009;24:92-6. ">Ko 2009</a>; <a href="./references#CD009557-bbs2-0014" title="Segura-CastilloJL , Estrada-RiveraO , Castro-CervantesJM , Cortés-FloresAO , Velázquez-RamírezGA , González-OjedaA . Reduction of lymphatic drainage posterior to modified radical mastectomy with the application of fibrin glue. Cirugia y Circujanos2005;73(5):345-50. ">Segura‐Castillo 2005</a>). There was no heterogeneity (I<sup>2</sup> = 0%) among included studies. Therefore, in the fixed‐effect model, the use of FG was not associated with an increased incidence of postoperative complications in participants undergoing breast and axillary surgery for cancer (RR 0.95; 95% CI 0.39 to 2.28, P value = 0.91; <a href="./references#CD009557-fig-0025" title="">Analysis 3.6</a>). </p> </section> <section id="CD009557-sec-0077"> <h5 class="title">Length of hospital stay</h5> <p>There was significant heterogeneity (I<sup>2</sup> = 40%) among two studies contributing to the combined calculation of this variable (<a href="./references#CD009557-bbs2-0004" title="GillyFN , FrançoisY , Sayag-BeaujardAC , GlehenO , BrachetA , VignalJ . Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. European Surgical Research1998;30:439-43. ">Gilly 1998</a>; <a href="./references#CD009557-bbs2-0006" title="JainPK , SowdiR , AndersonAD , MacFieJ . Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. The British Journal of Surgery2004;91:54-60. ">Jain 2004</a>). In the random‐effects model, the length of hospital stay was slightly shorter in the FG group (SMD ‐0.93; 95% CI ‐1.23 to ‐0.62, P value &lt; 0.001; <a href="./references#CD009557-fig-0026" title="">Analysis 3.7</a>). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009557-sec-0078" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009557-sec-0078"></div> <section id="CD009557-sec-0079"> <h3 class="title" id="CD009557-sec-0079">Summary of main results</h3> <p>Based on the results of this systematic review of 18 RCTs involving 1252 people undergoing breast and axillary surgery for breast cancer, the use of FG failed to reduce the incidence of postoperative seroma, mean volume of seroma, surgical site infection, postoperative complications and length of hospital stay. FG statistically reduced the total volume of drained seroma and duration of persistent seroma requiring frequent aspirations. </p> </section> <section id="CD009557-sec-0080"> <h3 class="title" id="CD009557-sec-0080">Overall completeness and applicability of evidence</h3> <p>The majority of the included RCTs evaluated the primary outcome of seroma incidence according to the pretrial analysis strategy (<a href="./references#CD009557-bbs2-0002" title="DinsmoreRC , HarrisJA , GustafsonRJ . Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. American Surgeon2000;66:982-5. ">Dinsmore 2000</a>; <a href="./references#CD009557-bbs2-0003" title="El-NakeebA . Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study. The Breast Journal2009;15:671-2. ">El‐Nakeeb 2009</a>; <a href="./references#CD009557-bbs2-0004" title="GillyFN , FrançoisY , Sayag-BeaujardAC , GlehenO , BrachetA , VignalJ . Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. European Surgical Research1998;30:439-43. ">Gilly 1998</a>; <a href="./references#CD009557-bbs2-0005" title="Gioffrè FlorioMA , MezzasalmaF , ManganaroT , PakravananH , CogliandoloA . The use of fibrin glue in the surgery of breast carcinoma. Il Giornale di Chirurgia1993;14:239-41. ">Gioffrè Florio 1993</a>; <a href="./references#CD009557-bbs2-0006" title="JainPK , SowdiR , AndersonAD , MacFieJ . Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. The British Journal of Surgery2004;91:54-60. ">Jain 2004</a>; <a href="./references#CD009557-bbs2-0007" title="JohnsonL , CusickTE , HelmerSD , OslandJS . Influence of fibrin glue on seroma formation after breast surgery. American Journal of Surgery2005;189:319-23. ">Johnson 2005</a>; <a href="./references#CD009557-bbs2-0008" title="KoE , HanW , ChoJ , LeeJW , KangSY , JungSY , et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. Journal of Korean Medical Science2009;24:92-6. ">Ko 2009</a>; <a href="./references#CD009557-bbs2-0009" title="LangerS , GuentherJM , DiFronzoLA . Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?American Surgeon2003;69:77-81. ">Langer 2003</a>; <a href="./references#CD009557-bbs2-0011" title="MooreM , Burak WE Jr, NelsonE , KearneyT , SimmonsR , MayersL , et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. Journal of the American College of Surgeons2001;192:591-9. ">Moore 2001</a>; <a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>; <a href="./references#CD009557-bbs2-0013" title="RuggieroR , ProcacciniE , GiliS , CremoneC , ParmeggianiD , ConzoG , et al. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. Il Giornale di Chirurgia2009;30:306-10. ">Ruggiero 2009</a>; <a href="./references#CD009557-bbs2-0014" title="Segura-CastilloJL , Estrada-RiveraO , Castro-CervantesJM , Cortés-FloresAO , Velázquez-RamírezGA , González-OjedaA . Reduction of lymphatic drainage posterior to modified radical mastectomy with the application of fibrin glue. Cirugia y Circujanos2005;73(5):345-50. ">Segura‐Castillo 2005</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>). The utilisation of seroma incidence as a primary end point following breast and axillary surgery was well targeted because the presence of seroma at the surgery site is associated with frequent re‐interventions, prolonged hospital stay, increased utilisation of healthcare resources, and delayed adjuvant chemotherapy or radiotherapy, or both. The primary outcome was thoroughly investigated and adequately reported in all RCTs including three trials (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>; <a href="./references#CD009557-bbs2-0010" title="MooreMM , NguyenDH , SpotnitzWD . Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. American Surgeon1997;63:97-102. ">Moore 1997</a>; <a href="./references#CD009557-bbs2-0015" title="TasinatoR , GodinaM , GriggioL , Da DaltGF , ScuderiA , ReschiglianE . Prevention of axillary seromas in patients who underwent limphadenectomy for breast cancer. Acta Chirurgica Italica1993;49(1):479-84. ">Tasinato 1993</a>), which investigated the incidence of postoperative seroma as a secondary outcome. The summated outcome of the primary variable was conclusive and may be considered adequate. However, due to the inadequate quality of the majority of the included RCTs, the generalised application of this evidence is difficult to recommend. The review authors believe that a major, multicentre, high‐quality RCT is mandatory to strengthen the existing evidence and validate these findings. </p> </section> <section id="CD009557-sec-0081"> <h3 class="title" id="CD009557-sec-0081">Quality of the evidence</h3> <p>There was a lack of adequate randomisation technique, allocation concealment, single or double blinding, ITT analysis, power of the study, conflict of interest declaration and ethics approval in the majority of the included trials (<a href="./references#CD009557-bbs2-0002" title="DinsmoreRC , HarrisJA , GustafsonRJ . Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. American Surgeon2000;66:982-5. ">Dinsmore 2000</a>; <a href="./references#CD009557-bbs2-0003" title="El-NakeebA . Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study. The Breast Journal2009;15:671-2. ">El‐Nakeeb 2009</a>; <a href="./references#CD009557-bbs2-0004" title="GillyFN , FrançoisY , Sayag-BeaujardAC , GlehenO , BrachetA , VignalJ . Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. European Surgical Research1998;30:439-43. ">Gilly 1998</a>; <a href="./references#CD009557-bbs2-0005" title="Gioffrè FlorioMA , MezzasalmaF , ManganaroT , PakravananH , CogliandoloA . The use of fibrin glue in the surgery of breast carcinoma. Il Giornale di Chirurgia1993;14:239-41. ">Gioffrè Florio 1993</a>; <a href="./references#CD009557-bbs2-0006" title="JainPK , SowdiR , AndersonAD , MacFieJ . Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. The British Journal of Surgery2004;91:54-60. ">Jain 2004</a>; <a href="./references#CD009557-bbs2-0007" title="JohnsonL , CusickTE , HelmerSD , OslandJS . Influence of fibrin glue on seroma formation after breast surgery. American Journal of Surgery2005;189:319-23. ">Johnson 2005</a>; <a href="./references#CD009557-bbs2-0008" title="KoE , HanW , ChoJ , LeeJW , KangSY , JungSY , et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. Journal of Korean Medical Science2009;24:92-6. ">Ko 2009</a>; <a href="./references#CD009557-bbs2-0009" title="LangerS , GuentherJM , DiFronzoLA . Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?American Surgeon2003;69:77-81. ">Langer 2003</a>; <a href="./references#CD009557-bbs2-0011" title="MooreM , Burak WE Jr, NelsonE , KearneyT , SimmonsR , MayersL , et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. Journal of the American College of Surgeons2001;192:591-9. ">Moore 2001</a>; <a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>; <a href="./references#CD009557-bbs2-0013" title="RuggieroR , ProcacciniE , GiliS , CremoneC , ParmeggianiD , ConzoG , et al. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. Il Giornale di Chirurgia2009;30:306-10. ">Ruggiero 2009</a>; <a href="./references#CD009557-bbs2-0014" title="Segura-CastilloJL , Estrada-RiveraO , Castro-CervantesJM , Cortés-FloresAO , Velázquez-RamírezGA , González-OjedaA . Reduction of lymphatic drainage posterior to modified radical mastectomy with the application of fibrin glue. Cirugia y Circujanos2005;73(5):345-50. ">Segura‐Castillo 2005</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>). Therefore, the quality of this evidence may be considered inadequate and biased. The sensitivity analysis (<a href="#CD009557-fig-0005">Figure 5</a>) performed on the combined analysis of all RCTs displayed the majority of trials away from the central bar, indicating diversity among the trials and potential outliers. </p> <div class="figure" id="CD009557-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 All trials analysis, outcome: 1.1 Incidence of postoperative seroma." data-id="CD009557-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 All trials analysis, outcome: 1.1 Incidence of postoperative seroma. </p> </div> </div> </div> </section> <section id="CD009557-sec-0082"> <h3 class="title" id="CD009557-sec-0082">Potential biases in the review process</h3> <p>The routine use of FG under skin flaps following breast and axillary surgery may not be recommended because of inadequate evidence and several limitations in the present review. There were significant differences in the inclusion and exclusion criteria among the included trials, such as the recruitment of people undergoing simultaneous breast and axillary surgery, breast surgery alone, axillary surgery alone, radical mastectomy and breast conserving surgery. Varying degrees of differences also existed among the trials for the definitions of 'post‐operative seroma', 'measurement scales' and diagnostic tools for postoperative seroma. The RCTs with fewer participants in this review may not have been sufficient to recognise small differences in the primary and secondary outcomes particularly in the absence of adequate power calculations. Therefore, the conclusion of this review should be viewed cautiously in current clinical practice. </p> </section> <section id="CD009557-sec-0083"> <h3 class="title" id="CD009557-sec-0083">Agreements and disagreements with other studies or reviews</h3> <p>Findings of this review are consistent with the previously reported nine RCTs (<a href="./references#CD009557-bbs2-0001" title="CipollaC , FricanoS , VieniS , GraceffaG , LicariG , TorciviaA , et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. Journal of Surgical Oncology2010;101:600-3. ">Cipolla 2010</a>; <a href="./references#CD009557-bbs2-0002" title="DinsmoreRC , HarrisJA , GustafsonRJ . Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. American Surgeon2000;66:982-5. ">Dinsmore 2000</a>; <a href="./references#CD009557-bbs2-0006" title="JainPK , SowdiR , AndersonAD , MacFieJ . Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. The British Journal of Surgery2004;91:54-60. ">Jain 2004</a>; <a href="./references#CD009557-bbs2-0007" title="JohnsonL , CusickTE , HelmerSD , OslandJS . Influence of fibrin glue on seroma formation after breast surgery. American Journal of Surgery2005;189:319-23. ">Johnson 2005</a>; <a href="./references#CD009557-bbs2-0013" title="RuggieroR , ProcacciniE , GiliS , CremoneC , ParmeggianiD , ConzoG , et al. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. Il Giornale di Chirurgia2009;30:306-10. ">Ruggiero 2009</a>; <a href="./references#CD009557-bbs2-0016" title="UdénP , AspegrenK , BalldinG , GarneJP , LarssonSA . Fibrin adhesive in radical mastectomy. European Journal of Surgery1993;159(5):263-5. ">Uden 1993</a>; <a href="./references#CD009557-bbs2-0017" title="UlusoyAN , PolatC , AlvurM , KandemirB , BulutF . Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. The Breast Journal2003;9(5):393-6. ">Ulusoy 2003</a>; <a href="./references#CD009557-bbs2-0018" title="VaxmanF , KolbeA , StricherF , ZundD , VolkmarP , GrosD , et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. European Surgical Research1995;27(5):346-52. ">Vaxman 1995</a>) and a meta‐analysis (<a href="./references#CD009557-bbs2-0029" title="CarlessPA , HenryDA . Systematic review and meta-analysis of the use of fibrin sealant to prevent seroma formation after breast cancer surgery. The British Journal of Surgery2006;93:810-9.">Carless 2006</a>) conferring that the application of FG under skin flaps following axillary and breast surgery for breast cancer failed to reduce the incidence of seroma formation, volume of seroma, length of hospital stay and postoperative complications. However, a few RCTs concluded that the use of FG leads to a significant reduction in postoperative drainage, earlier removal of drains and a decrease in the amount of aspirated fluid without a reduction in the incidence of postoperative seroma in people undergoing breast and axillary surgery for breast cancer (<a href="./references#CD009557-bbs2-0003" title="El-NakeebA . Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study. The Breast Journal2009;15:671-2. ">El‐Nakeeb 2009</a>; <a href="./references#CD009557-bbs2-0005" title="Gioffrè FlorioMA , MezzasalmaF , ManganaroT , PakravananH , CogliandoloA . The use of fibrin glue in the surgery of breast carcinoma. Il Giornale di Chirurgia1993;14:239-41. ">Gioffrè Florio 1993</a>; <a href="./references#CD009557-bbs2-0009" title="LangerS , GuentherJM , DiFronzoLA . Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?American Surgeon2003;69:77-81. ">Langer 2003</a>; <a href="./references#CD009557-bbs2-0010" title="MooreMM , NguyenDH , SpotnitzWD . Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. American Surgeon1997;63:97-102. ">Moore 1997</a>; <a href="./references#CD009557-bbs2-0011" title="MooreM , Burak WE Jr, NelsonE , KearneyT , SimmonsR , MayersL , et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. Journal of the American College of Surgeons2001;192:591-9. ">Moore 2001</a>; <a href="./references#CD009557-bbs2-0012" title="MustonenPK , HärmäMA , EskelinenMJ . The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scandinavian Journal of Surgery2004;93:209-12. ">Mustonen 2004</a>; <a href="./references#CD009557-bbs2-0013" title="RuggieroR , ProcacciniE , GiliS , CremoneC , ParmeggianiD , ConzoG , et al. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. Il Giornale di Chirurgia2009;30:306-10. ">Ruggiero 2009</a>; <a href="./references#CD009557-bbs2-0015" title="TasinatoR , GodinaM , GriggioL , Da DaltGF , ScuderiA , ReschiglianE . Prevention of axillary seromas in patients who underwent limphadenectomy for breast cancer. Acta Chirurgica Italica1993;49(1):479-84. ">Tasinato 1993</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009557-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-FIG-01" target="_blank"><b></b></a></p> </div><img alt="PRISMA flow chart showing trial selection methodology." data-id="CD009557-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA flow chart showing trial selection methodology.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/full#CD009557-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 All trials analysis, outcome: 1.1 Incidence of postoperative seroma." data-id="CD009557-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 All trials analysis, outcome: 1.1 Incidence of postoperative seroma. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/full#CD009557-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 All trials analysis, outcome: 1.5 Surgical site infection." data-id="CD009557-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 All trials analysis, outcome: 1.5 Surgical site infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/full#CD009557-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 All trials analysis, outcome: 1.6 Postoperative complications." data-id="CD009557-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 All trials analysis, outcome: 1.6 Postoperative complications.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/full#CD009557-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 All trials analysis, outcome: 1.1 Incidence of postoperative seroma." data-id="CD009557-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 All trials analysis, outcome: 1.1 Incidence of postoperative seroma. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/full#CD009557-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: All trials analysis, Outcome 1: Incidence of postoperative seroma" data-id="CD009557-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: All trials analysis, Outcome 1: Incidence of postoperative seroma</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: All trials analysis, Outcome 2: Mean volume of seroma" data-id="CD009557-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: All trials analysis, Outcome 2: Mean volume of seroma</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: All trials analysis, Outcome 3: Total volume of drained seroma" data-id="CD009557-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: All trials analysis, Outcome 3: Total volume of drained seroma</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: All trials analysis, Outcome 4: Number of days for persistent drainage" data-id="CD009557-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: All trials analysis, Outcome 4: Number of days for persistent drainage</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: All trials analysis, Outcome 5: Surgical site infection" data-id="CD009557-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: All trials analysis, Outcome 5: Surgical site infection</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: All trials analysis, Outcome 6: Postoperative complications" data-id="CD009557-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: All trials analysis, Outcome 6: Postoperative complications</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: All trials analysis, Outcome 7: Length of hospital stay" data-id="CD009557-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: All trials analysis, Outcome 7: Length of hospital stay</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Trials on mastectomy, Outcome 1: Incidence of postoperative seroma" data-id="CD009557-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Trials on mastectomy, Outcome 1: Incidence of postoperative seroma</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Trials on mastectomy, Outcome 2: Mean volume of seroma" data-id="CD009557-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Trials on mastectomy, Outcome 2: Mean volume of seroma</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Trials on mastectomy, Outcome 3: Total volume of drained seroma" data-id="CD009557-fig-0015" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Trials on mastectomy, Outcome 3: Total volume of drained seroma</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Trials on mastectomy, Outcome 4: Number of days for persistent drainage" data-id="CD009557-fig-0016" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Trials on mastectomy, Outcome 4: Number of days for persistent drainage</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Trials on mastectomy, Outcome 5: Surgical site infection" data-id="CD009557-fig-0017" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Trials on mastectomy, Outcome 5: Surgical site infection</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Trials on mastectomy, Outcome 6: Postoperative complications" data-id="CD009557-fig-0018" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Trials on mastectomy, Outcome 6: Postoperative complications</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Trials on mastectomy, Outcome 7: Length of hospital stay" data-id="CD009557-fig-0019" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: Trials on mastectomy, Outcome 7: Length of hospital stay</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Trials on mastectomy and axillary surgery, Outcome 1: Incidence of postoperative seroma" data-id="CD009557-fig-0020" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Trials on mastectomy and axillary surgery, Outcome 1: Incidence of postoperative seroma </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Trials on mastectomy and axillary surgery, Outcome 2: Mean volume of seroma" data-id="CD009557-fig-0021" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Trials on mastectomy and axillary surgery, Outcome 2: Mean volume of seroma </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Trials on mastectomy and axillary surgery, Outcome 3: Total volume of drained seroma" data-id="CD009557-fig-0022" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Trials on mastectomy and axillary surgery, Outcome 3: Total volume of drained seroma </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Trials on mastectomy and axillary surgery, Outcome 4: Number of days for persistent drainage" data-id="CD009557-fig-0023" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Trials on mastectomy and axillary surgery, Outcome 4: Number of days for persistent drainage </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Trials on mastectomy and axillary surgery, Outcome 5: Surgical site infection" data-id="CD009557-fig-0024" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: Trials on mastectomy and axillary surgery, Outcome 5: Surgical site infection </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-CMP-003.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Trials on mastectomy and axillary surgery, Outcome 6: Postoperative complications" data-id="CD009557-fig-0025" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-003.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-CMP-003.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3: Trials on mastectomy and axillary surgery, Outcome 6: Postoperative complications </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-003.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009557-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/urn:x-wiley:14651858:media:CD009557:CD009557-CMP-003.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Trials on mastectomy and axillary surgery, Outcome 7: Length of hospital stay" data-id="CD009557-fig-0026" src="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-003.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_t/tCD009557-CMP-003.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3: Trials on mastectomy and axillary surgery, Outcome 7: Length of hospital stay </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/media/CDSR/CD009557/image_n/nCD009557-CMP-003.07.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009557-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Fibrin glue instillation under skin flaps compared to no‐fibrin for breast and axillary surgery</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Fibrin glue instillation under skin flaps compared to no‐fibrin for breast and axillary surgery</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with breast and axillary surgery<br/><b>Settings:</b> <br/><b>Intervention:</b> fibrin glue instillation under skin flaps<br/><b>Comparison:</b> no‐fibrin </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No‐fibrin</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Fibrin glue instillation under skin flaps</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Incidence of</b> postoperative<b>seroma</b><br/>RR<br/>Follow‐up: 4‐16 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.02</b> <br/>(0.9 to 1.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1252<br/>(18 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>281 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>286 per 1000</b><br/>(253 to 326) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>229 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>234 per 1000</b><br/>(206 to 266) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean volume of seroma</b><br/>SMD<br/>Follow‐up: 4‐16 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean volume of seroma in the intervention groups was<br/><b>0.25 standard deviations lower</b><br/>(0.92 lower to 0.42 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>731<br/>(10 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.25 (‐0.92 to 0.42)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total volume of drained seroma</b><br/>SMD<br/>Follow‐up: 4‐16 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean total volume of drained seroma in the intervention groups was<br/><b>0.75 standard deviations lower</b><br/>(1.24 to 0.26 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>888<br/>(13 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.75 (‐1.24 to ‐0.26)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of days for persistent drainage</b><br/>SMD<br/>Follow‐up: 4‐16 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of days for persistent drainage in the intervention groups was<br/><b>0.59 standard deviations lower</b><br/>(0.95 to 0.23 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>861<br/>(13 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.59 (‐0.95 to ‐0.23)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Surgical site infection</b><br/>RR<br/>Follow‐up: 4‐16 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.05</b> <br/>(0.63 to 1.77) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1009<br/>(13 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>48 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 1000</b><br/>(30 to 85) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 1000</b><br/>(16 to 44) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Postoperative<b>complications</b><br/>RR<br/>Follow‐up: 4‐16 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.13</b> <br/>(0.63 to 2.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>981<br/>(11 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>39 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>44 per 1000</b><br/>(24 to 79) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>44 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 1000</b><br/>(28 to 90) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Length of hospital stay</b><br/>SMD<br/>Follow‐up: 4‐16 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay in the intervention groups was<br/><b>0.2 standard deviations lower</b><br/>(0.78 lower to 0.39 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>364<br/>(6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.2 (‐0.78 to 0.39)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>SMD:</b> standardised mean difference. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> There was inadequate randomisation technique and absence of power calculations, blinding and intention‐to‐treat analysis. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Fibrin glue instillation under skin flaps compared to no‐fibrin for breast and axillary surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/full#CD009557-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009557-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">All trials analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Incidence of postoperative seroma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.90, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Mean volume of seroma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>731</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐0.92, 0.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Total volume of drained seroma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>888</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.75 [‐1.24, ‐0.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Number of days for persistent drainage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>861</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.59 [‐0.95, ‐0.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Surgical site infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.63, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Postoperative complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>981</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.63, 2.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐0.78, 0.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">All trials analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009557-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Trials on mastectomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Incidence of postoperative seroma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>629</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.90, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Mean volume of seroma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>411</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.24 [‐0.63, 0.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Total volume of drained seroma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>629</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.83 [‐1.50, ‐0.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Number of days for persistent drainage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>539</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.36 [‐0.71, ‐0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Surgical site infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>522</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.60, 2.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Postoperative complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>437</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.59, 3.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [‐0.02, 0.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Trials on mastectomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009557-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Trials on mastectomy and axillary surgery</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Incidence of postoperative seroma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>496</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.72, 1.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Mean volume of seroma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.06 [‐3.23, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Total volume of drained seroma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>258</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.54 [‐1.06, ‐0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Number of days for persistent drainage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.68 [‐0.98, ‐0.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 Surgical site infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.44, 3.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.6 Postoperative complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>417</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.39, 2.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.7 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.93 [‐1.23, ‐0.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Trials on mastectomy and axillary surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009557.pub2/references#CD009557-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009557.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD009557-note-0008">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009557-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009557-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="fr#CD009557-note-0006">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD009557-note-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD009557-note-0003">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009557\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009557\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009557\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009557\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009557\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009557\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009557\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009557\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009557\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009557\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009557\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009557\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009557\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009557\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009557\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009557\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009557\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009557\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=EBp84H4P&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009557.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009557.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009557.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009557.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009557.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728763836"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009557.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728763840"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009557.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ecc6c4eebf56f',t:'MTc0MDcyODc2NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 